yttrium radioisotopes has been researched along with Carcinoma, Hepatocellular in 636 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (1.10) | 18.7374 |
| 1990's | 18 (2.83) | 18.2507 |
| 2000's | 86 (13.52) | 29.6817 |
| 2010's | 331 (52.04) | 24.3611 |
| 2020's | 194 (30.50) | 2.80 |
| Authors | Studies |
|---|---|
| Blanc, JF; Bordenave, L; Debordeaux, F; Lapuyade, B; Papadopoulos, P; Pinaquy, JB; Subreville, C | 1 |
| Mehta, N; Yao, FY | 2 |
| Dhir, M; Khan, A; Sayles, HR | 1 |
| Goyal, L; Wehrenberg-Klee, E | 1 |
| Chan, CY; Chong, HS; Choo, SP; Chow, PKH; Chung, A; Gogna, A; Goh, BKP; Goh, GB; Hennedige, T; Huang, HL; Irani, F; Kaya, NA; Koo, SL; Lam, J; Lee, J; Lim, JQ; Lim, TKH; Lo, R; Loke, K; Ng, D; Ng, MCH; Tai, D; Tan, SH; Tham, CK; Thng, CH; Toh, HC; Too, CW; Venkatanarasimha, N; Yeong, J; Zhai, W | 1 |
| Akarca, US; Akhan, O; Bilgiç, S; Bozkurt, MF; Çakaloğlu, Y; Cantaşdemir, M; Çapa Kaya, G; Çermik, TF; Er, Ö; Ilgıt, E; Küçük, NÖ; Numan, F; Parıldar, M; Türkmen, C | 1 |
| Amini, N; d'Abadie, P; Goffette, P; Jamar, F; Lhommel, R; Maanen, AV; Walrand, S | 1 |
| Bailly, C; Becker, S; Blanc, JF; Boucher, E; Bouvier, A; Chevallier, P; de Baere, T; Edeline, J; Garin, E; Goupil, J; Guiu, B; Manfredi, S; Mariano-Goulart, D; Mastier, C; Patel, B; Pinaquy, JB; Regnault, H; Rode, A; Sefrioui, D; Sengel, C; Somma, C; Tordo, J; Vibert, E; Vicaut, E | 1 |
| Brandi, G; Bruno, R; Carloni, R; De Giglio, A; Di Federico, A; Ricci, D; Rizzo, A | 1 |
| Boldt, G; Chow, R; Jairam, MP; Lock, M; Simone, CB; Swaminath, A | 1 |
| Aikimbaev, K; Ballı, HT; Boral, B; Pehlivan, UA; Sözütok, S | 1 |
| Frazzitta, AE; Kay, MD; Kuo, PH; Warhadpande, D | 1 |
| Aikimbaev, K; Balli, HT; Guney, IB; Kanmaz, T; Kupeli, S; Piskin, FC; Yagci-Kupeli, B | 1 |
| Alagoz, E; Arslan, N; Ercin, CN; Ince, S; Karadurmus, N; Karaman, B; Okuyucu, K; San, H | 1 |
| Amthauer, H; Böning, G; Gebauer, B; Hamm, B; Hardt, J; Jonczyk, M; Kahn, J; Lüdemann, W; Pustelnik, D; Wieners, G | 1 |
| Agirrezabal, I; Brennan, VK; Chatellier, G; Colaone, F; Pereira, H; Shergill, S; Vilgrain, V | 1 |
| Goldman, R; Janibek, N; Pillai, R; Roncali, E; Taebi, A; Vu, CT | 1 |
| Bermúdez, P; Burrel, M; Forner González, A | 1 |
| Berg, T; Denecke, T; Petersen, TO; Purz, S; Sabri, O; Steinhoff, KG; Van Boemmel, F; Veelken, R | 1 |
| Boudousq, V; Desmarets, G; Fidani, T; Goupil, J; Pouget, JP | 1 |
| Abboud, G; Bane, O; Doucette, J; Fiel, MI; Gnerre, J; Hectors, S; Kim, E; Law, A; Schwartz, M; Taouli, B; Vietti Violi, N | 1 |
| Hong, HS; Hwang, SH; Kim, D; Kim, DY; Kim, GM; Lee, HW; Lee, M; Park, MA; Yun, M | 1 |
| Feely, M; Geller, BS; Gonzalez, RS; Gubbiotti, M; Huber, AR; Numbere, N; Salaria, SN; Sharma, AK; Stashek, KM; Tondon, R | 1 |
| Alsuhaibani, HS; Cantasdemir, M; Dreher, M; Fowers, KD; Garin, E; Haste, P; Herrmann, K; Kappadath, SC; Lam, M; Maccauro, M; Salem, R; Sze, DY; Turkmen, C | 1 |
| Entezari, P; Gabr, A; Lewandowski, RJ; Salem, R | 1 |
| Balli, HT; Guney, IB; Kibar, M; Kucuker, KA; Unal, I | 1 |
| Amthauer, H; Bargellini, I; Bartenstein, P; Benckert, J; Berg, T; Gasbarrini, A; Gebauer, B; Iezzi, R; Klümpen, HJ; Loewe, C; Malfertheiner, P; Öcal, O; Pech, M; Philipp, A; Ricke, J; Sangro, B; Schütte, K; Seidensticker, M; Sengel, C; van Delden, O; Vandecaveye, V; Verslype, C; Zech, CJ | 1 |
| Bertaglia, V; Luciani, A; Pearce, J; Petrelli, F; Porcu, M; Saba, L; Scartozzi, M; Solinas, C | 1 |
| Bibok, A; Frakes, J; Hoffe, S; Jain, R; Kis, B; Parikh, N; Zhang, J | 1 |
| Aguado, A | 1 |
| Brandon, D; Chen, B; Cristescu, M; Elsayed, M; Galt, J; Kappadath, SC; Kokabi, N; Schuster, DM; Sethi, I; Switchenko, JM; Webster, LA | 1 |
| Chiesa, C; Fowers, K; Garin, E; Haste, P; Herman, JM; Kappadath, SC; Kim, E; Lam, M; Leung, T; Padia, SA; Salem, R; Sangro, B; Sze, DY; Toskich, B | 1 |
| Clark, CJ; Erali, RA; Howerton, R; Mangieri, CW; Shen, P; Strode, MA; Valenzuela, CD | 1 |
| Baum, Y; Bercu, ZL; Brandon, D; Cheng, B; Cristescu, MM; Kokabi, N; Loya, MF; Majdalany, BS; Schuster, D; Villalobos, A; Webster, LA; Xing, M | 1 |
| Aziz, H; Diaz, DA; Hamad, A; Kamel, IR; Pawlik, TM | 1 |
| D'Souza, D; Flanagan, S; Golzarian, J; Ragulojan, R; Sanghvi, T; Todatry, S; Young, S | 1 |
| Boas, FE; Park, JJ; Pedersoli, F | 1 |
| Arican, P; Bostanci, O; Ekmekcioglu, O; Erdem, U; Ozvar, H | 1 |
| Al Jammal, O; Berman, ZT; Duncan, DP; Hsieh, LJ; Minocha, J; Rockwell, HD; Rose, SC; Srinivas, S | 1 |
| Albrecht, T; Arnold, D; Bargellini, I; Bilbao, JI; Cianni, R; de Jong, N; Helmberger, T; Kolligs, F; Maleux, G; Munneke, G; Pereira, H; Peynircioglu, B; Sangro, B; Schaefer, N; Zeka, B | 1 |
| Cuneo, KC; Herr, DJ | 1 |
| Kokabi, N; Villalobos, A | 1 |
| Bello-Martinez, R; Charles, D; Chen, M; Fauveau, V; Kim, E; Lee, JY; Marinelli, B; Radell, J; Stocker, D; Taouli, B | 1 |
| Cho, EJ; Kim, HC; Kim, YJ; Lee, JH; Lee, YB; Nam, JY; Paeng, JC; Yoon, JH; Yu, SJ | 1 |
| Ahmed, O; Baker, T; Kwak, D; Liao, CY; Little, K; Marshall, E; Patel, M; Pillai, A; Ungchusri, E; Van Ha, T; Wang, Y; Yu, Q; Zangan, S | 1 |
| Boudjema, K; Bourien, H; Edeline, J; Garin, E; Jeddou, H; Robin, F; Rolland, Y; Sebai, A; Sulpice, L; Tzedakis, S; Uguen, T | 1 |
| Şener, N; Yakupoğlu, A | 1 |
| Brown, DB; Collins, ZS; Du, L; Gandhi, RT; Golzarian, J; Hund, HC; Kennedy, AS; Matsuoka, L; Sze, DY | 1 |
| Fidelman, N; Khanjyan, M; Pillai, A; Yu, Q | 1 |
| Akateh, C; Black, SM; Cloyd, JM; Conteh, L; Elliott, E; Miller, ED; Noonan, A; Pawlik, TM; Tsung, A | 1 |
| Amthauer, H; Bargellini, I; Bartenstein, P; de Toni, EN; Gasbarrini, A; Klümpen, HJ; Malfertheiner, P; Pech, M; Peck-Radosavljevic, M; Popovič, P; Ricke, J; Rosmorduc, O; Sangro, B; Schott, E; Seidensticker, M; Verslype, C | 1 |
| Cournane, S; Gray, L; Lucey, J; Manley, M; McCann, J; McCavana, J | 1 |
| Cutaia, C; Pacilio, M; Paradisi, BP; Pasquino, M; Pellerito, RE; Poli, M; Richetta, E; Stasi, M; Tabone, M; Valero, C | 1 |
| Buckstein, M; Fischman, A; Hardy-Abeloos, C; Kim, E; Lazarev, S; Moshier, E; Rosenzweig, K; Ru, M | 1 |
| Bercu, ZL; Dabrowiecki, A; Duszak, R; Elsayed, M; Faraj, R; Goldman, DT; Kokabi, N; Martin, JG; McMahon, JT; Newsome, J | 1 |
| Bishay, V; Kim, E; O'Connor, PJ; Pasik, SD; Radaelli, A; van der Bom, IM | 1 |
| Bernhardt, P; Chiesa, C; Chouin, N; Gabina, PM; Gear, J; Gleisner, KS; Konijnenberg, M; Stokke, C; Strigari, L; Walrand, S | 1 |
| Cardarelli-Leite, L; Chou, F; Chung, J; Hadjivassiliou, A; Ho, S; Klass, D; Lim, H; Liu, DM; Marquez, V; Tae Wan Kim, P; Walton, H | 1 |
| Bhutiani, N; Egger, ME; Hong, YK; Martin, RCG; McMasters, KM; Mercer, MK; O'Brien, SJ; Potts, MH; Priddy, EE; Scoggins, CR | 1 |
| Abdel-Rahman, O; Elsayed, Z | 2 |
| Brennan, VK; Colaone, F; Guardiola, L; Pollock, RF; Shergill, S | 1 |
| Cabrera, R; Firpi, R; Geller, BS; Gonzalo, DH; Ismael, MN; Johnson, MW; Lazarowicz, M; Limaye, AR; Morelli, G; Soldevila-Pico, C; Suman, A; Toskich, B; Vogel, JD; Zori, AG | 1 |
| Attenberger, U; Block, W; Faron, A; Fimmers, R; Kuetting, DLR; Luetkens, JA; Meyer, C; Pieper, CC; Sprinkart, AM; Thomas, D | 1 |
| Affonso, BB; Carvalho, VO; Falsarella, PM; Ferraz-Neto, BH; Galastri, FL; Garcia, RG; Motta-Leal-Filho, JMD; Nasser, F; Rezende, MB; Valle, LGM | 1 |
| Ahn, J; Al-Hakim, R; Billingsley, KG; Enestvedt, KK; Farsad, K; Jahangiri, Y; Kardosh, A; Kaufman, JA; Kolbeck, KJ; Lhewa, D; Maynard, E; Mayo, SC; Nabavizadeh, N; Naugler, WE; Orloff, SL; Schenning, RC; Tomozawa, Y; Zu, Q | 1 |
| Edeline, J; Garin, E | 1 |
| Canbay, A; Chatellier, G; Chow, PKH; Donghia, R; Gandhi, M; Guerra, V; Leandro, G; Malfertheiner, P; Pech, M; Pereira, H; Ricke, J; Venerito, M; Vilgrain, V | 1 |
| Alasadi, A; Ali, R; Baker, T; Boike, J; Borja-Cacho, D; Caicedo, JC; Desai, K; Flamm, S; Gabr, A; Ganger, D; Katariya, N; Kulik, L; Ladner, DP; Lewandowski, RJ; Maddur, H; Moore, C; Mora, RA; Mouli, S; Riaz, A; Salem, R; Thornburg, B | 1 |
| Baltacioglu, F; Erdil, TY; Eryuksel, E; Kesim, S; Ones, T; Ozguven, S; Tureli, D | 1 |
| Gates, VL; Gordon, AC; Harris, KR; Huang, X; Larson, AC; Lewandowski, RJ; Li, W; Lyu, T; Omary, RA; Procissi, D; Salem, R; White, SB; Yang, Y; Zhang, Z | 1 |
| Roncali, E; Taebi, A; Vu, CT | 1 |
| Sofocleous, CT; Vasiniotis Kamarinos, N | 1 |
| Kapila, N; McElroy, L; Samoylova, ML; Segovia, MC; Suhocki, P | 1 |
| Karatoprak, S; Kutlu, R | 1 |
| Benderli Cihan, Y | 1 |
| Chao, Y; Chen, JL; Hou, MC; Huang, YH; Lee, IC; Lee, RC; Liu, CA | 1 |
| Barron, B; Bercu, Z; Brandon, D; Cheng, B; Elsayed, M; Galt, J; Kokabi, N; Schuster, DM; Sethi, I; Xing, M | 1 |
| Amaddeo, G; Chalaye, J; Derbel, H; Ghosn, M; Itti, E; Kharrat, R; Kobeiter, H; Luciani, A; Mulé, S; Oubaya, N; Regnault, H; Tacher, V | 1 |
| Dane, B; Huang, C; King, MJ; Shanbhogue, K; Tong, A; Zhan, C | 1 |
| Bargellini, I; Boni, G; Bozzi, E; Cioni, R; Crocetti, L; Lorenzoni, G; Scalise, P; Traino, CA | 1 |
| Brennan, VK; Colaone, F; Pollock, RF; Shergill, S | 1 |
| Amaddeo, G; Assenat, E; Boudjema, K; Campillo-Gimenez, B; Chalaye, J; de Baere, T; Edeline, J; Fourcade, M; Garin, E; Grimaldi, S; Guiu, B; Hollebecque, A; Kafrouni, M; Kobeiter, H; Laffont, S; Le Sourd, S; Mariano-Goulart, D; Palard, X; Piron, L; Regnault, H; Robert, C; Rolland, Y; Sommacale, D; Tacher, V; Terroir-Cassou-Mounat, M; Tselikas, L; Vibert, E | 1 |
| Chung, JW; Joo, I; Kim, HC; Lee, M | 1 |
| Gabr, A; Johnson, GE; Lewandowski, RJ; Padia, SA; Toskich, BB | 1 |
| Geller, B; Grajo, JR; Montazeri, SA; Shah, J; Syed, M; Toskich, B | 1 |
| Brennan, VK; Colaone, F; Evans, R; Mullan, D; Muszbek, N; Remak, E; Ross, PJ; Shergill, S | 1 |
| Kao, YH | 1 |
| Ahn, SH; Jeon, MY; Kim, BK; Kim, DY; Kim, SU; Kim, Y; Lee, HA; Lee, JS; Park, JY; Seo, YS; Um, SH | 1 |
| Artzner, C; Castaneda Vega, SG; Dittmann, H; Grosse, U; Grözinger, G; Kupferschläger, J; la Fougere, C; Nikolaou, K; Vogel, J; Weissinger, M | 1 |
| Ahmed, O; Funaki, B; Lionberg, A; Navuluri, R; Nijhawan, K; Van Ha, T; Zangan, S | 1 |
| Ang, C; Buckstein, M; Ferket, BS; Kim, E; Marqueen, KE; Mazumdar, M | 1 |
| Kaplan, E; Kaplan, S | 1 |
| Chung, JW; Kim, HC; Kim, YJ; Lee, JH; Lee, YB; Nam, JY; Yoon, JH; Yu, SJ | 1 |
| Boyle, AW; Burns, JM; Croome, KP; Harnois, DM; Keaveny, AP; Liou, H; Mody, K; Patel, TC; Toskich, B | 1 |
| Fong, ZV; Qadan, M | 1 |
| Argiriadi, P; Bekki, Y; Facciuto, L; Facciuto, ME; Gunasekaran, G; Kamath, A; Kim, E; Lewis, S; Marti, J; Patel, RS; Schiano, TD; Simpson, W; Toshima, T | 1 |
| Buies, A; Côté, F; Daigle, G; F Turgeon, A; Hallet, J; Lemieux, S; Provencher, S | 1 |
| Battal, M; Bozdag Kaplan, N; Ekmekcioglu, O; Hasanefendioglu Bayrak, A; Tabakci, ON | 1 |
| Bishay, V; Boucher, E; Fowers, K; Johnson, GE; Kim, E; Lewandowski, R; Padia, SA; Riaz, A; Salem, R | 1 |
| Annet, L; Borbath, I; d'Abadie, P; Hesse, M; Jamar, F; Lhommel, R; Van den Eynde, M; Walrand, S | 1 |
| Bista, R; Goss, JA; Heczey, A; Khan, O; Kukreja, K; Loo, C; Lopez-Terrada, D; Mahvash, A; Masand, P; Nguyen, H; Patel, K; Vasudevan, SA; Whitlock, RS | 1 |
| Bercu, Z; Brandon, D; Cheng, B; Kokabi, N; Schuster, DM; Sethi, I; Villalobos, A; Wagstaff, W | 1 |
| Choi, JW; Chung, JW; Kim, HC; Kim, YJ; Lee, M; Paeng, JC | 1 |
| Bang, MH; Giang, DT; Ha, LN; Ky, TD; Lee, HW; Son, MH; Thinh, NT; Tien, DD; Van Thai, N | 1 |
| Chatellier, G; Durand-Zaleski, I; Mimouni, M; Pereira, H; Vilgrain, V; Zarca, K | 1 |
| Aaltonen, E; Farquharson, S; Gross, JS; Guichet, PL; Hickey, R; Horn, CJ; Taslakian, B; Zhan, C | 1 |
| Anton, K; Civan, J; Delaney, LJ; Eisenbrey, JR; Forsberg, F; Liu, JB; Lyshchik, A; Machado, P; O'Kane, P; Shaw, CM; Tan, A; Tantawi, M; Wessner, CE | 1 |
| Iñarrairaegui, M; Sangro, B | 1 |
| Akce, M; Behbahani, K; Bercu, Z; Elsayed, M; Kokabi, N; Majdalany, BS; Mao, H; Schuster, DM; Villalobos, A; Wagstaff, W | 1 |
| Akce, M; Bercu, Z; Cristescu, MM; Guo, M; Kokabi, N; Magliocca, J; Majdalany, BS; Villalobos, A; Wagstaff, W; Wedd, J; Whitmore, MJ; Zhang, J | 1 |
| Goh, BKP | 1 |
| Arepally, A; Stein, LL; Tully, MC | 1 |
| Abdelrazek Mohammed, MA; Chan, LS; Louie, JD; Poultsides, GA; Sze, DY; Wang, DS | 1 |
| Ettorre, GM; Levi Sandri, GB; Vennarecci, G | 1 |
| Hester, CA; Mokdad, AA; Singal, AG; Yopp, AC | 1 |
| Eggert, T; Greten, TF | 1 |
| Alagoz, E; Arslan, N; Erçin, CN; İnce, S; Karadurmuş, N; Karaman, B; Şan, H | 1 |
| Clerc, D; Demartines, N; Halkic, N; Melloul, E | 1 |
| Abeccassis, M; Abouchaleh, N; Ali, R; Asadi, AA; Atassi, R; Baker, T; Caicedo, JC; Desai, K; Fryer, J; Gabr, A; Ganger, D; Habib, A; Hickey, R; Hohlastos, E; Kulik, L; Lewandowski, RJ; Memon, K; Riaz, A; Salem, R; Vouche, M | 1 |
| Bonne, L; De Hertogh, G; Deroose, CM; Dresen, RC; Klompenhouwer, EG; Laenen, A; Maleux, G; Vandevaveye, V; Verslype, C | 1 |
| Alian, A; Aucejo, FN; Bennett, S; Estfan, B; Gill, A; Kalva, SP; Kapoor, B; Levitin, A; McDevitt, JL; McLennan, G; Narayanan Menon, KV; Pillai, AK; Sands, M | 1 |
| Bellavia, RJ; Broadwell, SR; Stein, JP; Wang, EA | 1 |
| Claroni, C; Covotta, M; Forastiere, E; Naccarato, A; Pelagalli, L; Torregiani, G; Tribuzi, S | 1 |
| Abecassis, M; Abouchaleh, N; Al Asadi, A; Ali, R; Caicedo, JC; Gabr, A; Katariya, N; Kulik, L; Lewandowski, RJ; Maddur, H; Mora, R; Riaz, A; Salem, R | 1 |
| Angileri, SA; Barile, A; Carrafiello, G; Caspani, F; De Palma, D; Del Sole, A; Floridi, C; Fontana, F; Lucignani, G; Masciocchi, C; Pesapane, F | 1 |
| Abecassis, M; Abouchaleh, N; Al Asadi, A; Ali, R; Gabr, A; Kulik, L; Lewandowski, RJ; Mora, RA; Riaz, A; Salem, R | 1 |
| Abouchaleh, N; Ali, R; Baker, T; Caicedo, J; Gabr, A; Kallini, JR; Kulik, L; Lewandowski, RJ; Riaz, A; Salem, R | 1 |
| Chow, PK; Gandhi, M; Gebski, V | 1 |
| Chandramohan, S; Chow, PKH; Damodharan, K; Gogna, A; Lo, RHG; Tong, KTA; Venkatanarasimha, N | 1 |
| Kaseb, AO | 1 |
| Adam, R; Allaham, W; Assenat, E; Aubé, C; Barraud, H; Bouattour, M; Brenot-Rossi, I; Bronowicki, JP; Castera, L; Chatellier, G; Costentin, C; Couturier, O; Dinut, A; Gerolami, R; Guiu, B; Ilonca, AD; Itti, E; Laurent, V; Lebtahi, R; Lewin, M; Luciani, A; Mathias, E; Mundler, O; Oberti, F; Pageaux, GP; Perdrisot, R; Pereira, H; Raoul, JL; Ronot, M; Samuel, D; Sarran, A; Seitz, JF; Sibert, A; Silvain, C; Tasu, JP; Vidal, V; Vilgrain, V | 1 |
| Khan, S; Lee, EW | 1 |
| Boudjema, K; Brun, V; Edeline, J; Garin, E; Haumont, LA; Laffont, S; Le Sourd, S; Lenoir, L; Loyer, P; Mesbah, H; Palard, X; Pracht, M; Rolland, Y; Ugen, T | 1 |
| Hu, YW; Huang, PI; Lee, RC; Lin, KH; Lin, YY; Liu, CA; Liu, CS; Liu, YM; Tseng, HS; Wang, TH | 1 |
| Abdul Latiff, JB; Allen, JC; Chan, CY; Chang, JPE; Cheah, FK; Choo, SP; Chow, PKH; Chung, AYF; Goh, BKP; Kam, JH; Lee, VTW; Low, ASC; Ng, DCE; Tai, DW; Teo, JY | 1 |
| Camacho, JC; Kim, HS; Kokabi, N; Xing, M | 1 |
| Bhoori, S; Cascella, T; Chiesa, C; Lanocita, R; Maccauro, M; Marchianò, A; Mazzaferro, V; Morosi, C; Romito, R; Sposito, C; Spreafico, C; Vaiani, M | 1 |
| Chung, JW; Kim, HC; Kim, YJ; Paeng, JC | 1 |
| Bucerius, J; de Vos-Geelen, J; Mitea, C; van der Leij, C; van der Pol, J | 1 |
| Finn, RS; Llovet, JM | 1 |
| Hasegawa, K; Kokudo, N; Kokudo, T | 1 |
| Campillo-Gimenez, B; Edeline, J; Garin, E; Rolland, Y | 1 |
| Chatellier, G; Dinut, A; Pereira, H; Vilgrain, V | 1 |
| French, J; Haugk, B; Littler, P; Mafeld, S; Manas, D; Tiniakos, D | 1 |
| Cappelli, A; Cucchetti, A; Golfieri, R; Mosconi, C; Pettinato, C | 1 |
| Alessio, AM; Chan, KT; Johnson, GE; Kwan, SW; Lewis, DH; Monsky, W; Padia, SA; Vaidya, S; Wilson, AE | 1 |
| Agazzi, R; Colledan, M; Conte, G; De Giorgio, M; Fagiuoli, S; Iegri, C; Lucà, MG; Nani, R; Nicora, C; Pinelli, D; Sala, F; Sarti, D; Schranz, M; Sironi, S; Virotta, G | 1 |
| Bargellini, I; Boni, G; Caramella, D; Cioni, R; Crocetti, L; Lorenzoni, G; Traino, AC; Turini, FM | 1 |
| Mazzaferro, V; Sposito, C; Spreafico, C | 1 |
| Addo, E; Brown, DB; Devulapalli, KK; El-Haddad, G; Farsad, K; Fidelman, N; Fleming, J; Gaba, RC; Gandhi, R; Johnson, MS; Kerlan, RK; Kwan, SW; Lazar, AA; Liu, DM; Lokken, RP; Miller, M; Morrison, J; Nutting, C; Pennycooke, KA; Rose, SC; Soulen, MC; White, SB | 1 |
| Dugan, M; Ganguli, S; Goyal, L; Wehrenberg-Klee, E; Zhu, AX | 1 |
| Bagni, O; Cianni, R; D'Agostini, A; Di Costanzo, GG; Filippi, L; Pelle, G; Schillaci, O; Tortora, R | 1 |
| Barazani, S; Heiba, SI; Kim, E; Lekperic, S; Titano, JJ; Voutsinas, N | 1 |
| Bagni, O; Filippi, L; Schillaci, O | 1 |
| Bilbao, JI; Cappelli, A; De Benedittis, C; Deppe, I; Golfieri, R; Mosconi, C; Ricke, J; Rodriguez-Fraile, M; Sangro, B; Sangro, P; Terzi, E | 1 |
| Abecassis, M; Abouchaleh, N; Ali, R; Baker, T; Caicedo, J; Gabr, A; Katariya, N; Lewandowski, RJ; Riaz, A; Salem, R | 1 |
| Geller, BS; Kapp, M; Pepin, EW; Shah, JL; Thornton, LM; Toskich, BB | 1 |
| Aguado, A; Geller, JI; Gupta, A; Haberle, S; Kukreja, KU; Patel, MN; Qi, Z; Ristagno, R; Tiao, GM; Towbin, AJ | 1 |
| Cascella, T; Mazzaferro, V; Monteleone, M; Pellegrinelli, A; Sposito, C; Virdis, M | 1 |
| An, C; Choi, JY; Han, K; Kim, DY; Kim, GM; Kim, MJ; Kim, S; Won, JY | 1 |
| Abuqbeitah, M; Akgün, E; Akovali, B; Asa, S; Demir, M; Gülsen, F; Sager, S; Sahin, O; Sayman, H; Sönmezoglu, K; Uslu-Beşli, L; Yeyin, N | 1 |
| Florman, S; Kim, E; Labgaa, I; Melloul, E; Schwartz, M; Tabrizian, P; Thung, SN; Titano, J | 1 |
| Liu, DM; Toskich, BB | 1 |
| Chung, J; Hadjivassiliou, A; Klass, D; Liu, D | 1 |
| Liu, DM; Malhotra, A; Talenfeld, AD | 1 |
| Gandhi, RT; Ganguli, S; Wehrenberg-Klee, E | 1 |
| Kim, E; Patel, RS; Titano, JJ | 1 |
| Al Asadi, A; Ali, R; Gabr, A; Lewandowski, RJ; Mora, R; Mouli, S; Riaz, A; Salem, R | 1 |
| Bell, J; Chiesa, C; Fowers, K; Garin, E; Hamilton, B; Herman, J; Kappadath, SC; Lam, M; Leung, T; Padia, SA; Portelance, L; Salem, R; Sze, D | 1 |
| D'Angelo, R; Fiore, F; Gatta, G; Serra, N; Somma, F; Stoia, V | 1 |
| Lai, Q; Levi Sandri, GB; Lucatelli, P | 1 |
| Arveschoug, AK; Grønbæk, H; Kramer, SM; Nielsen, DT; Nielsen, JE; Ott, P; Staanum, PF; Villadsen, GE | 1 |
| Ayres, D; Balijepalli, C; Ebrahim, S; Gabr, A; Kallini, JR; Kanters, S; Lewandowski, RJ; Mills, E; Salem, R; Thorlund, K | 1 |
| Antipova, O; Daddario, L; Gordon, AC; Harris, K; Larson, A; Maxey, E; Paunesku, T; Procissi, D; Smith, A; Vogt, S; White, S; Woloschak, GE | 1 |
| Amanavicius, N; Arveschoug, AK; Kramer, SJ; Staanum, PF; Villadsen, GE | 1 |
| Lewandowski, RJ; Toskich, B | 1 |
| Howerton, L | 1 |
| Cho, EJ; Cho, HJ; Choi, NR; Hong, JH; Hur, MH; Hyun, D; Kim, HC; Kim, J; Kim, JM; Kim, JY; Kim, YJ; Lee, JH; Lee, KW; Lee, YB; Paeng, JC; Park, MK; Sinn, DH; Suh, KS; Yi, NJ; Yoon, JH; Yu, SJ | 1 |
| Cornman-Homonoff, J; Mabey, JG; Madoff, DC | 1 |
| Baker, T; Boudjema, K; Gamblin, TC; Geller, D; Kazimi, M; Salem, R; Tabrizian, P; Zendejas, I | 1 |
| Feliu, J; Minaya-Bravo, A; Prieto, I; Rodriguez-Salas, N; Viñal, D | 1 |
| Chen, T; Flanagan, S; Golzarian, J; Sanghvi, T; Young, S | 1 |
| Bodei, L; Chiesa, C; Cremonesi, M; Flamen, P; Garin, E; Gnesin, S; Herrmann, K; Konijnenberg, M; Kracmerova, T; Lam, M; Luster, M; Weber, M | 1 |
| Allimant, C; Edeline, J; Garin, E; Guiu, B; Salem, R | 1 |
| Helmberger, T; Pereira, PL | 1 |
| Rajabi, H; Talebi, AS; Watabe, H | 1 |
| Croome, KP; De la Garza-Ramos, C; Devcic, Z; Frey, GT; Harnois, D; Krishnan, S; LeGout, JD; Lewis, AR; Lewis, JT; McKinney, JM; Montazeri, SA; Patel, T; Paz-Fumagalli, R; Ritchie, CA; Sella, DM; Toskich, BB; Vidal, L | 1 |
| Borbath, I; d'Abadie, P; Hesse, M; Jamar, F; Lhommel, R; Walrand, S | 1 |
| Ge, L; He, Y; Li, D; Mu, C; Shen, G; Wu, X; Xu, Z; Zhang, W; Zhao, L | 1 |
| Chiesa, C; Maccauro, M; Mazzaglia, S | 1 |
| Braat, AJAT; Bruijne, J; Bruijnen, R; IJzermans, JNM; Lam, MGEH; Man, RA; Moelker, A; Reinders, MTM; Smits, MLJ; Sprengers, D; van Erpecum, KJ; Vegt, E | 1 |
| Ng, DCE; Tay, KH; Tong, AK; Zhuang, KD | 1 |
| Cheng, YF; Chow, PK; Kim, YH; Lau, WY; Lee, RC; Leung, TW; Liu, DM; Mao, Y; Ng, DC; Teng, GJ | 1 |
| Gasbarrini, A; Ibba, F; Iezzi, R; Maestri, M; Manfredi, R; Pallozzi, M; Pompili, M; Ponziani, FR; Posa, A; Santopaolo, F; Tanzilli, A | 1 |
| Edeline, J; Garin, E; Guiu, B; Palard, X; Rolland, Y | 1 |
| Choi, TW; Joo, I; Kim, HC | 1 |
| Arora, M; Devcic, Z; Frey, G; Lewis, AR; McKinney, JM; Montazeri, SA; Padula, CA; Paz-Fumagalli, R; Ritchie, C; Toskich, BB | 1 |
| Al-Omary, A; Chan, C; Chan, MV; Chang, J; Cheng, R; Clark-Dickson, M; Danta, M; Davison, SA; Gupta, S; Hillhouse, JW; Huo, YR; Jebeili, H; Laube, R; Lee, AU; Levy, MT; Liu, K; Lockart, I; Nguyen, V; Prince, DS; Rogan, C; Schlaphoff, G; Strasser, SI; Thailakanathan, C; Tiwari, N; Xiang, H; Zekry, A | 1 |
| Alexander, HC; Bartlett, ASJR; Chu, MJJ; Han, CH; Holden, AH; Nguyen, CH; Tarr, GP; Thomas, RH | 1 |
| Aikimbaev, K; Balli, HT; Burak, IG; Pehlivan, UA; Piskin, FC; Sozutok, S | 1 |
| Dadparvar, S; Kushner, D; Namous, N | 1 |
| Allimant, C; Bargellini, I; Bell, J; Bilbao, JI; Bouvier, A; Chapiro, J; Chiesa, C; de Baere, T; Decaens, T; Denys, A; Duran, R; Edeline, J; Garin, E; Ghelfi, J; Gregory, J; Guiu, B; Helmberger, T; Irani, F; Lam, M; Lewandowski, R; Liu, D; Loffroy, R; Madoff, DC; Mastier, C; Ronot, M; Salem, R; Sangro, B; Sze, D; Tselikas, L; Vilgrain, V; Vouche, M | 1 |
| Agirrezabal, I; Brennan, VK; Carion, PL; Pollock, RF; Shergill, S; von Oppen, N | 1 |
| Brunson, C; Hennemeyer, CT; Kuo, PH; McGregor, H; McNiel, D; Patel, MV; Woodhead, G | 1 |
| Cimsit, C; Engur, CO; Erdil, TY; Eryuksel, E; Ones, T; Ozguven, S; Sen, F; Soydemir, E; Turoglu, HT | 1 |
| Gichoya, J; Kokabi, N; Villalobos, A; Wagstaff, WV | 1 |
| Arndt-Webster, L; Bercu, Z; Brandon, D; Chen, B; Cristescu, M; Davarpanahfakhr, A; Elsayed, M; Galt, J; Kappadath, SC; Kokabi, N; Schuster, DM; Sethi, I | 1 |
| Fidelman, N; Heller, M; Lam, A; Lokken, RP; Wu, X | 1 |
| Farsad, K; Golzarian, J; Haghshomar, M; Torkian, P; Wallace, S; Young, SJ | 1 |
| Argemí, J; Sangro, B | 1 |
| Hyun, D; Lee, HN | 1 |
| Desai, K; Entezari, P; Gabr, A; Gordon, AC; Kalyan, A; Kulik, L; Lewandowski, RJ; Ranganathan, S; Riaz, A; Salem, R; Thornburg, B | 1 |
| Gates, V; Gordon, AC; Knight, GM; Lewandowski, R; Riaz, A; Salem, R; Talwar, A | 1 |
| Aikimbaev, K; Ballı, HT; Burak, İG; Pişkin, FC | 1 |
| Asadi, H; Briody, H; Duong, D; Hannah, A; Hodgson, R; Kok, HK; Lee, MJ; Leong, S; Maingard, J; Yeoh, SW; Yong, TL | 1 |
| Bibok, A; Czibor, S; Fábián, K; Györke, T; Horváthy, D | 1 |
| Choi, JW; Choi, R; Kim, HC; Lee, M | 1 |
| Johnson, G; Laidlaw, G; McGregor, H | 1 |
| Abdul Hadi, MFR; Ashour, NI; Hashikin, NAA; Musa, AS; Ying, CK | 1 |
| Celebioglu, EC; Demir, B; Dursun, E; Idilman, R; Kucuk, NO; Oz, DK; Ozkan, E; Soydal, C | 1 |
| Barbato, F; Denys, A; Dreher, M; Fowers, KD; Garin, E; Gates, V; Geller, B; Haste, P; Herrmann, K; Kappadath, C; Lam, M; Mahvash, A; Palard-Novello, X; Salem, R; Schaefer, N; Tann, M | 1 |
| Dagher, NN; Gu, P; Hickey, RM; Park, JS; Ruohoniemi, D; Shanbhogue, KP; Taslakian, B; Wei, J; Welling, TH; Zhan, C | 1 |
| Bastiaannet, R; de Jong, HWAM; Lam, MGEH; Lodge, MA | 1 |
| Al Asadi, A; Ali, R; Das, A; Gabr, A; Lewandowski, RJ; Mora, R; Mouli, S; Riaz, A; Salem, R | 1 |
| Amaddeo, G; Calderaro, J; Chalaye, J; Ghosn, M; Luciani, A; Mulé, S; Tacher, V | 1 |
| Cassinotto, C; Guiu, B; Piron, L | 1 |
| Chao, S; Fung, J; Grace, K; Hassan, S; Kim, E; Lewandowski, RJ; Martin, RCG; Rosner, BI; Salem, R; Sichlau, MJ | 1 |
| Ahn, SH; Han, KH; Jeon, MY; Kim, BK; Kim, DY; Kim, SU; Lee, HA; Lee, JS; Lim, TS; Park, JY; Seo, YS; Um, SH | 1 |
| Chatellier, G; Hawkins, NS; Palmer, DH; Pereira, H; Ross, PJ; Vilgrain, V | 1 |
| Caskey, JS; Kay, MD; Kuo, PH; McMillan, NA; Woodhead, GJ | 1 |
| Gabr, A; Gao, R; Kulik, L; Lewandowski, RJ; Mouli, S; Riaz, A; Salem, R | 1 |
| Adams, LA; Ferguson, J; Garas, G; Jeffrey, GP; Khoo, T; Knuiman, M; MacQuillan, G; Ooi, J; Preen, DB; Samuelson, S; Tibballs, J; Wallace, MC | 1 |
| Akinwande, O; Gibby, W; Kim, SK; Lancia, S; Malone, CD; Ramaswamy, RS; Tsai, R | 1 |
| Caicedo, JC; Gabr, A; Ganger, D; Gates, VL; Hohlastos, E; Kalyan, A; Katariya, N; Kulik, L; Lewandowski, RJ; Maddur, H; Moore, C; Mouli, SK; Ranganathan, S; Riaz, A; Salem, R | 1 |
| Bhoori, S; Bormolini, G; Brusa, A; Capozza, A; Cascella, T; Cavallo, A; Chiesa, C; De Nile, MC; Maccauro, M; Marchianò, A; Mazzaferro, V; Mazzaglia, S; Mira, M; Seregni, E; Spreafico, C; Tagliabue, G | 1 |
| Abdalla, A; Abdallah, MA; Andrews, JC; Bampoh, S; Fleming, CJ; Glubranson, LA; Hassan, MA; Mahipal, A; Nelson, M; Onyirioha, K; Roberts, LR; Taha, W; Wiseman, GA; Wongjarupong, N | 1 |
| Chung, JW; Joo, I; Kim, HC; Kim, YJ; Lee, M; Paeng, JC | 1 |
| Baranski, T; Chapman, W; Chaterjee, D; Foltz, G; Kim, H; Lin, AJ | 1 |
| Gabr, A; Johnson, GE; Kim, E; Lewandowski, RJ; Padia, S; Riaz, A; Salem, R | 1 |
| Beigelman, C; Boughdad, S; Denys, A; Digklia, A; Duran, R; Girardet, R; Hocquelet, A; Meyer, M; Schaefer, N; Tsoumakidou, G; Vermersch, M | 1 |
| Aaltonen, ET; Gross, JS; Hickey, RM; Horn, JC; Maslowski, JM; Patel, A; Sista, AK | 1 |
| Bane, O; Hectors, SJ; Kennedy, P; Kim, E; Lewis, S; Said, D; Schwartz, M; Segall, M; Taouli, B | 1 |
| Bird, V; Dev, A; Gow, P; Hirsch, RD; Kemp, W; Lubel, J; Mills, C; Mishra, G; Nicoll, AJ; Roberts, SK; Sawhney, R; Sood, S | 1 |
| Arnold, D; Bilbao, JI; Cianni, R; de Jong, N; Golfieri, R; Helmberger, T; Maleux, G; Munneke, G; Pech, M; Pellerin, O; Peynircioglu, B; Pfammatter, T; Sangro, B; Schaefer, N | 1 |
| Arnold, D; Bilbao, JI; Bouvier, A; Greget, M; Helmberger, T; Kaufmann, N; Loffroy, R; Maleux, G; Mastier, C; Pelage, JP; Pellerin, O; Peynircioglu, B; Ronot, M; Sangro, B; Schaefer, N; Sengel, C; Tselikas, L; Urdániz, M; Vilgrain, V | 1 |
| Bishay, V; Cedillo, M; Charles, D; Fischman, A; Kim, E; Lookstein, R; Marinelli, B; Marron, T; Murthy, S; Nowakowski, S; Pasik, SD; Patel, RS; Ranade, M; Schwartz, M; Sung, M | 1 |
| Ahmed, O; Pillai, A | 1 |
| Arndt, L; Bercu, Z; Cheng, B; Cristescu, M; Ermentrout, RM; Kokabi, N; Magliocca, JF; Majdalany, BS; Sellers, MT; Shah, A; Villalobos, A; Wagstaff, W; Wedd, J; Xing, M | 1 |
| Boike, JR; Borja-Cacho, D; Caicedo-Ramirez, JC; Christopher, DA; Flamm, SL; Gabr, A; Ganger, DR; Gordon, AC; Gupta, AN; Katariya, NN; Kulik, LM; Ladner, DP; Lewandowski, RJ; Maddur, H; Moore, CM; Riaz, A; Salem, R; Thornburg, BG | 1 |
| Padia, SA | 1 |
| Dugan, AJ; Fowler, KJ; Furlan, A; Kapoor, H; Nisiewicz, MJ; Owen, JW | 1 |
| Croome, KP; Devcic, Z; Frey, GT; LeGout, JD; Lewis, AR; Lewis, JT; Montazeri, SA; Olson, MT; Patel, TC; Paz-Fumagalli, R; Ritchie, CA; Sella, DM; Toskich, B; Vidal, LL | 1 |
| Ahn, SH; Kim, BK; Kim, DY; Kim, SU; Kim, Y; Lee, HW; Lee, JS; Park, JY | 1 |
| Bercu, Z; Brandon, DC; Cheng, B; Galt, J; Kokabi, N; Schuster, DM; Sethi, I; Villalobos, A; Wagstaff, W | 1 |
| Preston, E; Shaida, N | 1 |
| Gabr, A; Lewandowski, RJ; Mouli, S; Pan, MM; Riaz, A; Salem, R | 1 |
| Klaassen, NJM; Konijnenberg, MW; Nijsen, JFW; Overduin, CG; Roosen, J; Verheij, M; Westlund Gotby, LEL | 1 |
| Alem, Z; Chang, SD; Chung, J; Egri, C; Elsayes, KM; Harris, A; Liu, D; Murray, TE | 1 |
| Hendlisz, A; Sclafani, F | 1 |
| Ahmed, O; Funaki, B; Patel, M; Te, H; Van Ha, T; Zangan, S | 1 |
| Acoba, JD; Kwee, SA; Landsittel, DP; Rho, YS; Sato, MM; Srivastava, A; Wong, LL | 1 |
| Benguerfi, S; Bourien, H; Edeline, J; Estrade, F; Garin, E; Le Du, F; Le Sourd, S; Lescure, C; Muzellec, L; Palard, X; Pracht, M; Rolland, Y | 1 |
| Ahmed, A; Bibok, A; Choi, J; El-Haddad, G; Fishman, MN; Frakes, J; Hoffe, S; Jain, R; Kis, B; Mhaskar, R; Parikh, N; Zhang, J | 1 |
| Delman, AM; Fong, ZV; Gabr, A; Qadan, M; Salem, R; Shah, SA | 1 |
| Bhattacharya, R; Harris, WP; Hippe, DS; Horton, KJ; Ingraham, CR; Johnson, GE; Kogut, MJ; Kwan, S; Monsky, WL; Padia, SA; Park, JO; Vaidya, S | 1 |
| Edeline, J; Garin, E; Pallard, X | 1 |
| Golzarian, J; Young, S | 1 |
| Deltenre, P; Denys, A; Duran, R | 1 |
| Friedman, T; Kishore, S; Madoff, DC | 1 |
| Kim, HC | 1 |
| Bellendorf, A; Dechêne, A; Goebel, J; Goebel, T; Lazik-Palm, A; Mueller, S; Sulke, M; Theysohn, J; Umutlu, L | 1 |
| Gabr, A; Kallini, JR; Lewandowski, RJ; Salem, R | 2 |
| Al-Hakim, R; Benenati, JF; Gandhi, RT | 1 |
| Ahn, SH; Han, KH; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Lee, HW; Park, JY; Seong, J; Song, JE; Song, K; Won, JY | 1 |
| Patel, T; Toskich, B | 1 |
| N'Kontchou, G; Nahon, P; Nault, JC; Seror, O; Sutter, O | 1 |
| Ahmed, AF; Cabrera, R; Collinsworth, A; Esnakula, A; Geller, BS; Grajo, JR; Samreen, N; Shah, JL; Sistrom, CL; Toskich, BB; Zendejas, I | 1 |
| Choi, W; Han, K; Han, KH; Kim, DY; Kim, GM; Kim, MD; Kim, YS; Kwon, JH; Lee, DY; Lee, J; Won, JY | 1 |
| Chatterji, M; Kim, E; Lewis, S; Makkar, J; Semaan, S; Taouli, B | 1 |
| Devereaux, K; Louie, JD; Poultsides, GA; Titan, AL | 1 |
| Abouchaleh, N; Ali, R; Asadi, AA; Desai, K; Gabr, A; Kallini, JR; Lewandowski, RJ; Miller, FH; Mora, RA; Mouli, S; Riaz, A; Salem, R; Thornburg, B; Yaghmai, V | 1 |
| Abecassis, M; Abouchaleh, N; Ali, R; Asadi, AA; Atassi, B; Atassi, R; Benson, AB; Caicedo, J; Desai, K; Flamm, S; Gabr, A; Ganger, D; Habib, A; Hickey, R; Kallini, JR; Kulik, L; Lewandowski, RJ; Miller, FH; Mora, R; Mouli, S; Mulcahy, MF; Riaz, A; Salem, R; Sato, K; Thornburg, B; Vouche, M; Yaghmai, V | 1 |
| Pua, U; Quek, LHH | 1 |
| Bouazza, F; Delatte, P; Deleporte, A; Demetter, P; Donckier, V; Flamen, P; Galdon, MG; Garcia, CA; Hendlisz, A; Katsanos, G; Lemaire, M; Levillain, H; Lucidi, V; Vanderlinden, B; Vouche, M | 1 |
| Bae, SH; Bartlett, A; Cheow, PC; Choo, SP; Chotipanich, C; Chow, PKH; Cua, IHY; Gandhi, M; Gebski, V; Goh, ASW; Goh, BKP; Han, HS; Hung, CF; Jong, YW; Khasbazar, A; Khin, MW; Kim, YH; Kok, KYY; Law, CS; Lee, RC; Lekurwale, G; Lesmana, LA; Liang, PC; Liew, WM; Lim, K; Lo, RHG; Lobo, RR; Low, AS; Mak, KSW; Manuaba, TW; Ng, DCE; Ong, J; Peng, CY; Raj, A; Soo, KC; Tan, SB; Tay, KH; Teh, CSC; Thng, CH; Yoon, HK; Yoong, BK | 1 |
| Akinwande, O; Chang, R; Charalel, R; Mills, A; Noda, C; Tao, Y; Thayer, D | 1 |
| Abouchaleh, N; Ali, R; Gabr, A; Gordon, AC; Kallini, J; Lewandowski, RJ; Riaz, A; Salem, R; Uddin, OM | 1 |
| D'Souza, D; Flanagan, S; Golzarian, J; Sanghvi, T; Taylor, A; Young, S | 1 |
| Chung, JW; Kim, HC; Kim, YJ; Lee, JH; Suh, KS | 1 |
| Brunkhorst, T; Kirchner, T; Kirstein, MM; Marquardt, S; Rodt, T; Vogel, A; Wacker, F; Werncke, T | 1 |
| Amini, N; Borbath, I; dʼAbadie, P; Goffette, P; Lhommel, R | 1 |
| d'Abadie, P; Hesse, M; Jamar, F; Lhommel, R; Walrand, S | 1 |
| Ardisson, V; Bouvry, C; Edeline, J; Garin, E; Lepareur, N; Loyer, P; Palard, X | 1 |
| Arnold, CA; Lam-Himlin, D; Pezhouh, MK; Pittman, ME; VandenBussche, C; Voltaggio, L | 1 |
| Chu, KF; DePietro, A; Ganguli, S; Li, MD; Liu, RW; Wehrenberg-Klee, E; Wu, V; Zurkiya, O | 1 |
| Frey, GT; Lewis, A; McKinney, M; Paz-Fumagalli, R; Ritchie, C; Toskich, BB; Vidal, LLC | 1 |
| French, J; Hayhurst, H; Jackson, R; Littler, P; Mafeld, S; Manas, D; Moir, J | 1 |
| Besa, C; Gordic, S; Hectors, S; Kihira, S; Kim, E; Taouli, B; Wagner, M; Zanato, R | 1 |
| Chen, YF; Gaba, RC; Guzman, G; Huang, YH; Lokken, RP; Park, BV | 1 |
| Takayasu, K | 1 |
| Kim, DY; Kim, YH | 1 |
| Kim, BK; Kim, DY; Kim, EH; Kim, SU | 1 |
| Atassi, R; Ganger, D; Gupta, R; Kulik, L; Lewandowski, RJ; Memon, K; Miller, FH; Mulcahy, MF; Ryu, RK; Salem, R; Vouche, M | 1 |
| Boucher, E; Boudjema, K; Boulic, A; Clément, B; Edeline, J; Garin, E; Le Du, F; Lenoir, L; Pracht, M; Raoul, JL; Rolland, Y | 1 |
| Helmberger, T; Jakobs, TF; Mahnken, AH; Maleux, G; Spreafico, C | 1 |
| Mazzaferro, V; Salem, R; Sangro, B | 1 |
| Bettinger, D; Euringer, W; Knüppel, E; Roessle, M; Schultheiβ, M; Spangenberg, HC; Thimme, R | 1 |
| Chan, JK; Luo, DL | 1 |
| Boucher, E; Boudjema, K; Clement, B; Edeline, J; Garin, E; Guillygomarc'h, A; Laffont, S; Lenoir, L; Mesbah, H; Mesbah, M; Porée, P; Pracht, M; Quehen, E; Raoul, JL; Rolland, Y; Sulpice, L | 1 |
| Chen, PJ; Cheng, SQ; Chow, P; Han, KH; Lau, WY; Lee, RC; Leung, T; Poon, RT; Sangro, B | 1 |
| Abecassis, M; Atassi, R; Baker, T; Ganger, D; Hickey, R; Kulik, L; Lewandowski, RJ; Memon, K; Miller, FH; Mulcahy, M; Nayar, R; Salem, R; Vouche, M; Yaghmai, V | 1 |
| Iñarrairaegui, M; Pardo, F; Sangro, B | 1 |
| Ahmadzadehfar, H; Bilbao, JI; Cappelli, A; Carpanese, L; Cianni, R; Ettorre, GM; Ezziddin, S; Fiore, F; Gasparini, D; Geatti, O; Giampalma, E; Golfieri, R; Haug, AR; Izzo, F; Jakobs, TF; Lastoria, S; Notarianni, E; Paprottka, PM; Pizzi, G; Rodriguez, M; Saltarelli, A; Sangro, B; Vit, A; Wilhelm, K | 1 |
| Calvo, A; Ferrero, A; Tabone, M; Viganò, L | 1 |
| Arepally, A; Lam, MG; Prince, JF; Samim, M; van den Bosch, MA; van den Hoven, AF; Zonneberg, BA; Zonnenberg, BA | 1 |
| Alessio, A; Kwan, SW; Lewis, DH; Minoshima, S; Padia, SA; Vaidya, S | 1 |
| Abecassis, M; Atassi, R; Baker, T; Caicedo, JC; Fryer, J; Gaba, RC; Ganger, D; Gates, VL; Hickey, R; Kulik, L; Lewandowski, RJ; Memon, K; Mulcahy, MF; Riaz, A; Ryu, RK; Salem, R; Sato, K; Vouche, M | 1 |
| Gates, VL; Lewandowski, RJ; Salem, R | 1 |
| Bruix, J; Burrel, M; Reig, M | 1 |
| Law, MW; Lee, VH; Leung, TW; Liu, RK; Ma, VW; Ng, SC; Tso, WK | 1 |
| Cho, KR; Cho, SB; Choe, JG; Choi, JY; Chun, HJ; Chung, JW; Gwon, DI; Han, KH; Heo, J; Joo, YE; Kim, CW; Kim, DY; Kim, JK; Kim, YH; Lee, HC; Lee, KH; Park, BJ; Uhm, SH; Yoon, JH | 1 |
| Bauer, J; Galvan, L; Han, E; Lan, JQ; Meller, R; Morris, KT | 1 |
| Gates, VL; Lewandowski, RJ; Memon, K; Minocha, J; Omary, R; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Amesur, N; Chen, HW; Geller, DA; Humar, A; Marsh, JW; Sukato, D; Tohme, S; Tsung, A; Zajko, AB | 1 |
| Bockisch, A; Ertle, J; Lauenstein, TC; Müller, S; Nensa, F; Schlaak, JF; Sipilae, S; Theysohn, JM | 1 |
| Camacho, JC; El-Rayes, BF; Kim, HS; Kokabi, N; Kooby, DA; Xing, M | 1 |
| Carpizo, DR; Gendel, VM; Gensure, RH; Greene, SJ; Jabbour, SK; Moore, DF; Nosher, JL; Yu, X | 1 |
| Ahmadzadehfar, H; Duan, H; Haug, AR; Hoffmann, M; Walrand, S | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Meyer, C; Pieper, CC | 1 |
| Courtright, KR; Kotloff, RM | 1 |
| Acuff, SN; Bourgeois, AC; Bradley, YC; Chang, TT; Pasciak, AS | 1 |
| Barron, BJ; Camacho, JC; Galt, JR; Kim, HS; Kokabi, N; Schuster, DM; Xing, M | 1 |
| Chiesa, C; Maccauro, M; Mazzaferro, V; Spreafico, C | 1 |
| Behnke, M; Bornstein, K; Cotterell, A; Fisher, RA; Fulcher, A; Lee, DD; Posner, MP; Ramanathan, R; Sharma, A; Stravitz, RT; Sydnor, M | 1 |
| Bui, JT; Casadaban, LC; Dikopf, MS; Gaba, RC; Lu, Y; Parvinian, A; Zivin, SP | 1 |
| Ettorre, GM; Laurenzi, A; Vennarecci, G | 1 |
| Baker, T; Ganger, D; Gates, VL; Habib, A; Hickey, R; Kulik, LM; Lewandowski, RJ; Memon, K; Mulcahy, MF; Ryu, RK; Salem, R; Vouche, M; Wang, E; Wang, J | 1 |
| Choo, SP; Chow, PK; Gandhi, M; Goh, AS; Han, HS; Khin, MW; Lai, HK; Lim, TG; Lo, RH; Poon, DY; Singh, H; Soo, KC; Tan, SB; Tay, KH | 1 |
| Alkadhi, H; Morsbach, F; Pfammatter, T; Puippe, G; Reiner, CS; Sah, BR; Schaefer, N | 1 |
| Abecassis, M; Al-Saden, P; Baker, T; Cotliar, J; Ganger, D; Habib, A; Karp, J; Koppe, S; Kulik, L; Lacouture, M; Lewandowski, RJ; Mulcahy, MF; Salem, R; Vouche, M | 1 |
| Abecassis, M; Baker, T; Caicedo, JC; Fryer, J; Ganger, D; Habib, A; Hickey, R; Hohlastos, E; Kim, E; Kulik, L; Lewandowski, RJ; Mulcahy, M; Salem, R; Sato, KT; Vouche, M; Ward, TJ | 1 |
| Cheung, CH; Cheung, MT; Chia, NH; Chou, SQ; Kwok, PC; Lam, TW; Law, CK; Leung, KC; Szeto, LT; Tong, CM; Yuen, PK | 1 |
| Camacho, JC; Kim, HS; Kitajima, H; Kokabi, N; Mittal, PK; Qiu, D; Xing, M | 1 |
| Bernardi, M; Bolondi, L; Cappelli, A; Cucchetti, A; Erroi, V; Fiumana, S; Golfieri, R; Gramenzi, A; Granito, A; Marinelli, S; Mosconi, C; Pettinato, C; Trevisani, F | 1 |
| Habib, A; Hickey, R; Kim, E; Lewandowski, R; Salem, R; Sato, KT; Vouche, M | 1 |
| N'Kontchou, G; Nahon, P; Nault, JC; Seror, O; Trinchet, JC | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bruhman, J; Ezziddin, S; Meyer, C; Pieper, CC; Sabet, A; Wasmuth, JC | 1 |
| Allen, JC; Cheah, FK; Chow, PK; Goh, AS; Goh, BK; Khor, AY; Lo, RH; Ng, DC; Ng, JJ; Sim, HS; Teo, JY | 1 |
| Coveler, A; Harris, WP; Kwan, SW; Monsky, WL; Padia, SA; Roudsari, B | 1 |
| Shouval, D | 1 |
| Brown, KT | 1 |
| Justinger, C; Kollmar, O; Schuld, J; Seidel, R; Sperling, J; Ziemann, C | 1 |
| Bester, L; Danta, M; Golani, S; Kapoor, J; Meteling, B; Morris, DL; Saxena, A | 1 |
| Bruix, J; Forner, A; Gilabert, M; Raoul, JL | 1 |
| Fletcher, JW; Hutchins, GD; Johnson, MS; Lea, WB; Tann, M; Tapp, KN | 1 |
| Jung, SW; Kim, DS; Kim, Y; Suh, SO; Yu, YD | 1 |
| Arbizu, J; Domínguez-Prado, I; Elosúa, C; García-Velloso, MJ; Martí-Climent, JM; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Fraile, M; Vigil, C | 1 |
| Garin, E; Lepareur, N; Lopez, A; Noiret, N | 1 |
| Jung, JY; Kim, CH; Kim, CS; Kim, JD; Kim, YH; Ryu, HS; Seo, YS; Shin, E; Um, SH; Yim, HJ; Yim, SY | 1 |
| Dhingra, S; Fiel, MI; Kim, E; Mabel Ko, H; Schwartz, M; Thung, SN; Ward, SC | 1 |
| Bhattacharya, R; Chewning, RH; Hippe, DS; Ingraham, CR; Johnson, GE; Kogut, MJ; Kwan, SW; Monsky, WL; Padia, SA; Vaidya, S; Valji, K | 1 |
| Kafadar, C; Kara, K; Mutlu, H; Sivrioglu, AK | 1 |
| Lewandowski, RJ; Miller, FH; Salem, R; Vouche, M | 1 |
| Bas, A; Cantasdemir, M; Gulsen, F; Kabasakal, L; Kantarci, F; Numan, F; Samanci, C | 1 |
| Lewandowski, RJ; Minocha, J; Salem, R | 1 |
| Benito, A; Bilbao, JI; D'Avola, D; Haug, A; Hoffmann, RT; Iñarrairaegui, M; Jakobs, T; Kolligs, FT; Martinez-Cuesta, A; Nagel, JM; op den Winkel, M; Rodriguez, M; Sangro, B; Tatsch, K; Trumm, C; Zech, CJ | 1 |
| Abdel-Rehim, M; Castéra, L; Chatellier, G; Lebtahi, R; Ronot, M; Sibert, A; Vilgrain, V | 1 |
| Abdel-Rehim, M; Ronot, M; Sibert, A; Vilgrain, V | 1 |
| Erxleben, C; Gebauer, B; Geisel, D; Hamm, B; Heimann, U; Powerski, MJ; Scheurig-Münkler, C | 1 |
| Bartenstein, P; Fendler, WP; Goritschan, A; Hacker, M; Haug, AR; Ilhan, H; Jakobs, TF; Paprottka, P | 1 |
| Delattre, BM; Ratib, O; Terraz, S; Wissmeyer, M; Zaidi, H | 1 |
| Boucher, E; Boudjema, K; Breton, M; Clement, B; Edeline, J; Garin, E; Icard, N; Laffont, S; Lenoir, L; Mesbah, H; Raoul, JL; Rohou, T; Rolland, Y; Sulpice, L | 1 |
| Edeline, J; Garin, E; Rolland, Y | 1 |
| Akyuz, F; Karaca, C; Keskin, S; Kuyumcu, S; Ozkan, ZG; Poyanli, A; Saglam, S; Turkmen, C; Ucar, A; Yilmaz, E | 1 |
| Abdelfattah, MR; Al-Sebayel, M; Alsuhaibani, H; Broering, D | 1 |
| Cappelli, A; Golfieri, R; Gramenzi, A; Mosconi, C; Pettinato, C; Trevisani, F | 1 |
| Amesur, N; Chalhoub, D; Geller, DA; Han, K; Marsh, JW; Orons, P; Sukato, DC; Tohme, S; Tsung, A; Zajko, A | 1 |
| Adib, S; Bize, P; Boubaker, A; Denys, A; Duran, R; Guiu, B; Pracht, M | 1 |
| Camacho, JC; El-Rayes, BF; Kim, HS; Knechtle, SJ; Kokabi, N; Spivey, JR; Xing, M | 1 |
| Desai, K; Habib, A; Hickey, R; Lewandowski, R; Salem, R; Thornburg, B | 1 |
| Bol, GH; de Jong, HW; Lam, MG; Prince, JF; van den Bosch, MA; van Rooij, R | 1 |
| Braat, AJ; Braat, MN; de Jong, HW; Lam, MG; Prince, JF; Smits, ML; van den Bosch, MA; van den Hoven, AF | 1 |
| Mahnken, AH | 1 |
| Chapiro, J; Duran, R; Geschwind, JF; Schernthaner, RE | 1 |
| Aliberti, G; Bhoori, S; Camerini, T; Carrara, M; Chiesa, C; Civelli, E; Crippa, F; De Nile, MC; Facciorusso, A; Lanocita, R; Maccauro, M; Marchianò, A; Mazzaferro, V; Migliorisi, M; Mira, M; Morosi, C; Negri, A; Padovano, B; Pellizzari, S; Romito, R; Seregni, E; Sposito, C; Spreafico, C | 1 |
| Akinwande, O; Brown, R; Edwards, J; Kim, D; Martin, RC; Philips, P; Scoggins, C | 1 |
| Alkadhi, H; Gordic, S; Morsbach, F; Pfammatter, T; Puippe, G; Reiner, CS; Schaefer, N; Veit-Haibach, P; Wurnig, M | 1 |
| Apte, A; Kalantzis, G; Leventouri, T; Shang, C | 1 |
| Behr, SC; Fidelman, N; Kerlan, RK; Kohi, MP; Kolli, PK; LaBerge, JM; Olorunsola, OG; Taylor, AG; Tong, RT | 1 |
| Biederman, DM; Facciuto, ME; Fischman, AM; Florman, S; Gunasekaran, G; Kim, E; Lee, KM; Nowakowski, FS; Patel, RS; Pierobon, ES; Schwartz, M; Tabori, NE; Titano, JJ | 1 |
| Best, J; Bockisch, A; Dechene, A; Gerken, G; Haubold, J; Lauenstein, TC; Müller, S; Ruhlmann, M; Theysohn, JM; Umutlu, L | 1 |
| Edeline, J; Garin, E; Laffont, S; Rolland, Y | 1 |
| Chang, Y; Lund, J; Sanoff, HK; Stavas, JM; Stürmer, T | 1 |
| Abdullah, BJ; Chung, LY; Dahalan, R; Hashikin, NA; Ng, KH; Perkins, AC; Yeong, CH | 1 |
| Fidelman, N; Kerlan, RK | 1 |
| Bargellini, I; Fornaro, L; Giorgi, L; Sacco, R | 1 |
| Adhoute, X; Blanc, JF; Boucher, E; Boudjema, K; Campillo-Gimenez, B; Clément, B; Crouzet, L; Edeline, J; Garin, E; Guillygomarc'h, A; Lenoir, L; Pracht, M; Rohou, T; Rolland, Y | 1 |
| Angelelli, B; Ascanio, S; Bolondi, L; Cappelli, A; Galaverni, MC; Garzillo, G; Giampalma, E; Golfieri, R; Monari, F; Mosconi, C; Pettinato, C; Pini, P; Piscaglia, F; Renzulli, M; Terzi, E; Trevisani, F | 1 |
| Ji, H; Li, Y; Lu, H; Zhang, Y; Zhao, X | 1 |
| Clément, B; Coulouarn, C; Crouzet, L; Edeline, J; Garin, E; Lepareur, N; Pracht, M | 1 |
| Laroia, AT; Laroia, ST; Morales, SA | 1 |
| Hickey, RM; Lewandowski, RJ; Salem, R | 1 |
| Abdel-Rahman, OM; Elsayed, Z | 1 |
| Arenas, JI; Buades-Mateu, J; Bustamante, FJ; de la Rosa, PA; de la Torre, MA; Gil, C; Iñarrairaegui, M; Lorente, S; Lué, A; Sangro, B; Serrano, MT; Testillano, M | 1 |
| Bugiantella, W; Carnelutti, A; Leo, CA; Lorenzin, D; Pravisani, R; Risaliti, A; Soardo, G; Umberto, B | 1 |
| Chow, PK; de Villa, VH; Gogna, A; Irani, FG; Kim, YH; Lau, WY; Lee, RC; Liang, PC; Lim, KB; Lo, RH; Ng, DC; Santos-Ocampo, RS; Tai, DW; Teoh, YL; Win, KM | 1 |
| Abecassis, M; Baker, T; Benson Iii, AB; Desai, K; Gabr, A; Ganger, D; Gates, VL; Hickey, R; Kulik, L; Lewandowski, RJ; Mouli, S; Ralph Kallini, J; Salem, R; Thornburg, B | 1 |
| Alshebeeb, K; Biederman, DM; Facciuto, ME; Fischman, AM; Florman, S; Gunasekaran, G; Kim, E; Nowakowski, FS; Patel, RS; Pierobon, ES; Schwartz, M; Tabori, NE; Titano, JJ | 1 |
| Han, KH; Kim, DY | 2 |
| Baheti, AD; Bhargava, P; Dunham, GM; Ingraham, CR; Katz, DS; Lall, C; Li, D; Madoff, DC; Moshiri, M; Park, JO | 1 |
| Bae, SH; Cho, YY; Chung, JW; Gwak, GY; Heo, J; Kim, do Y; Kim, HC; Kim, YH; Kim, YJ; Lee, M | 1 |
| Gupta, A; Kousik, V; Promila, P; Verma, R | 1 |
| Andreoli, JM; Baker, T; Gabr, A; Hickey, R; Kallini, JR; Kircher, S; Kulik, L; Lewandowski, RJ; Salem, R | 1 |
| Hippe, DS; Johnson, GE; Monsky, WL; Padia, SA; Valji, K | 1 |
| Altendorf-Hofmann, A; Bauschke, A; Freesmeyer, M; Malessa, C; Schierz, JH; Settmacher, U; Teichgraeber, U; Winkens, T | 1 |
| Antonini, M; Cianni, R; Colasanti, M; D'Offizi, G; Ettorre, GM; Golfieri, R; Laurenzi, A; Lepiane, P; Levi Sandri, GB; Lionetti, R; Meniconi, RL; Pellicelli, AM; Pizzi, G; Santoro, R; Sciuto, R; Vennarecci, G | 1 |
| Brun, V; Edeline, J; Garin, E; Haumont, LA; Laffont, S; Le Sourd, S; Lenoir, L; Mesbah, H; Pracht, M; Rohou, T; Rolland, Y | 1 |
| Charles, HW; Deipolyi, AR; Park, J; Patel, P | 1 |
| Gabr, A; Kallini, JR; Kulik, L; Lewandowski, RJ; Salem, R | 1 |
| Abecassis, M; Baker, T; Benson, AB; Desai, K; Gabr, A; Ganger, D; Gordon, AC; Hickey, R; Kallini, J; Kulik, L; Lewandowski, RJ; Miller, FH; Mouli, S; Mulcahy, MF; Rademaker, A; Salem, R; Sato, K; Thornburg, B; Yaghmai, V | 1 |
| Bhoori, S; Ciani, O; Facciorusso, A; Mazzaferro, V; Rognoni, C; Sommariva, S; Tarricone, R | 1 |
| ElTawil, R; Kwon, D; Lobo, L; Pendola, F; Picado, O; Portelance, L; Ripat, C; Sharma, R; Venkat, S; Yakoub, D; Yechieli, R | 1 |
| Chaudhari, P; Dash, A; Gupta, S; Pandey, U; Samuel, G; Singh, G; Subramanian, S; Tyagi, M; Venkatesh, M | 1 |
| Biederman, DM; Bishay, VL; Fischman, AM; Kim, E; Lookstein, RA; Nowakowski, FS; Patel, RS; van der Bom, IM; Ward, TJ | 1 |
| Bisi, G; Finessi, M; Gallio, E; Pellerito, RE; Richetta, E; Ropolo, R; Stasi, M | 1 |
| Bartlett, DL; Chung, MH; Doherty, MG; Marsh, JW; Varma, MK; Wright, GP | 1 |
| Dhanasekaran, R; Kim, HS; Knechtle, SJ; Parekh, S; Sakaria, S; Spivey, J; Xing, M; Zhang, D | 1 |
| Braat, MN; Lam, MG; van den Bosch, MA; van Erpecum, KJ; Zonnenberg, BA | 1 |
| Rodriguez, M; Sangro, B | 1 |
| Abuodeh, Y; Ahmed, KA; Anaya, DA; Biebel, B; Choi, J; El-Haddad, G; Frakes, JM; Hoffe, SE; Kim, R; Kim, Y; Kis, B; Malafa, M; Naghavi, AO; Sweeney, J; Venkat, PS | 1 |
| Bastiaannet, R; de Jong, HW; Lam, MG; Prince, JF; Smits, ML; van den Bosch, MA | 1 |
| Ayache, JB; Bane, O; Besa, C; Ehman, RL; Gordic, S; Kennedy, P; Kim, E; Taouli, B; Wagner, M | 1 |
| Chidi, AP; Sud, V; Tohme, S; Tsung, A | 1 |
| Acuff, S; Fu, Y; Kaman, A; Neveu, M; Osborne, DR; Syed, M | 1 |
| Atassi, B; Deng, J; Kulik, LM; Larson, AC; Miller, FH; Mulcahy, MF; Naik, NK; Omary, RA; Rhee, TK; Ryu, RK; Salem, R | 1 |
| Amesur, NB; Devera, MB; Fontes, P; Gamblin, TC; Geller, DA; Heckman, JT; Holloway, SE; Marsh, JW; Nalesnik, M; Steel, JL | 1 |
| Palmer, D | 1 |
| Buck, D; Carr, BI; Federle, M; Fontes, P; Nalesnik, MA | 1 |
| Atassi, B; Gates, VL; Ibrahim, S; Kennedy, AS; Kulik, L; Lewandowski, RJ; Liu, DM; Mulcahy, MF; Omary, RA; Parikh, P; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Dudeck, O; Malfertheiner, P; Mönkemüller, K; Ricke, J; Roessner, A; Schmitt, J; Zimmermann, L | 1 |
| Brown, DB; Carr, BI; Gonsalves, CF | 1 |
| Antoch, G; Beckebaum, S; Broelsch, CE; Ertl, J; Fouzas, I; Hilgard, P; Lang, H; Molmenti, EP; Nowak, KM; Paul, A; Sgourakis, G; Sotiropoulos, GC | 1 |
| Abecassis, M; Baker, T; Gates, V; Giakoumis Spear, G; Kulik, L; Lewandowski, RJ; Miller, FH; Mulcahy, MF; Nayar, R; Omary, RA; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Antoch, G; Gerken, G; Haberkorn, U; Hamami, M; Hilgard, P; Müller, S; Sauerwein, WS | 1 |
| Calkins, A; Carter, D; Coldwell, D; Dezarn, WA; Garafalo, M; Gates, VL; Gulec, S; Jakobs, T; Kennedy, AS; Liu, D; McNeillie, P; Nag, S; Nutting, C; Rose, S; Salem, R; Sangro, B; Sapareto, S; Savin, M; Warner, R; Wertman, D | 1 |
| Ellis, SF; Hahl, MJ; Martin, RC; McMasters, KM; Ravindra, KV; Scoggins, CR; Tatum, CM; Woodall, CE | 1 |
| Abecassis, MM; Baker, TB; Gaba, RC; Gates, V; Ibrahim, SM; Kulik, LM; Lewandowski, RJ; Mulcahy, MF; Omary, RA; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Antoch, G; Bockisch, A; Hamami, ME; Heusner, T; Hilgard, P; Müller, S; Poeppel, TD | 1 |
| Strunk, HM | 1 |
| Kulik, L; Lewandowski, RJ; Riaz, A; Salem, R | 1 |
| Defreyne, L; Lambert, B; Peeters, M; Van De Wiele, C | 1 |
| Bilbao, JI; Garrastachu, P; Iñarrairaegui, M; Martinez-Cuesta, A; Rodriguez, M; Sangro, B | 1 |
| Amthauer, H; Bornschein, J; Malfertheiner, P; Mohnike, K; Pech, M; Peters, N; Ricke, J; Rühl, R; Schütte, K; Seidensticker, M | 1 |
| Abecassis, M; Baker, T; Ibrahim, SM; Kulik, LM; Lewandowski, RJ; Miller, FH; Mulcahy, MF; Omary, R; Riaz, A; Ryu, RK; Salem, R; Sato, KT; Senthilnathan, S | 1 |
| Busuttil, R; Kee, S; Lee, P | 1 |
| Bakalyar, D; Beauvais, M; Campbell, J; Feng, W; Savin, M; Schultz, CC | 1 |
| Aloia, TA; Barakat, O; Connelly, J; Gaber, AO; Ghobrial, RM; Haykal, N; Michel, D | 1 |
| Abecassis, M; Atassi, B; Baker, T; Benson, AB; Gates, V; Gupta, R; Ibrahim, S; Kulik, L; Lewandowski, RJ; Miller, FH; Mulcahy, MF; Newman, SB; Omary, RA; Riaz, A; Ryu, RK; Salem, R; Sato, KT; Wang, E | 1 |
| Ardisson, V; Boucher, E; Boudjema, K; Bourguet, P; Garin, E; Laffont, S; Raoul, JL; Rolland, Y | 1 |
| Baker, T; Gates, VL; Kulik, LM; Lewandowski, RJ; Mulcahy, MF; Omary, R; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Roche, A | 1 |
| Andrews, JC; Fleming, CJ; Gansen, DN; Roberts, LR; Wiseman, GA | 1 |
| Andrews, JC; Gansen, DN; Kwo, PY; Luna, LE; Mettler, TA; Misra, VL; Roberts, LR; Wiseman, GA | 1 |
| Chamsuddin, A; Delman, KA; Egnatashvili, V; Kauh, J; Kim, HS; Kooby, DA; Srinivasan, S; Staley, CA | 1 |
| Riaz, A; Salem, R | 1 |
| Aracil, C; Bruix, J; Bustamante, J; de la Mata, M; Del Val, A; Matilla, A; Pascasio, JM; Pascual, S; Reig, M; Rodríguez, M; Turnes, J; Varela, M | 1 |
| Alegre, F; Arbizu, J; Benito, A; Bilbao, JI; D'Avola, D; Herrero, JI; Iñarrairaegui, M; Martinez-Cuesta, A; Prieto, J; Quiroga, J; Rodríguez, M; Sangro, B | 1 |
| Branch, RA; Buch, SC; Carr, BI; Kondragunta, V | 1 |
| Deleporte, A; Flamen, P; Hendlisz, A | 1 |
| Deng, J; Duke, E; Ibrahim, SM; Kulik, L; Larson, AC; Lewandowski, RJ; Miller, FH; Mulcahy, MF; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
| Antoch, G; Bockisch, A; Ertle, J; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Hilgard, P; Poeppel, T | 1 |
| David, J; Patel, NM; Yuan, J | 1 |
| Antoch, G; Bockisch, A; Ertle, J; Forsting, M; Hamami, M; Heusner, TA; Hilgard, P; Mueller, SP | 1 |
| Abecassis, M; Atassi, B; Baker, T; Benson, AB; Gates, VL; Gupta, R; Kennedy, A; Kulik, L; Lewandowski, RJ; Millender, L; Mulcahy, MF; Omary, R; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Al-Kadhi, Y; Al-Mana, H; Al-Mutawa, A; Al-Sebayel, M; Al-Sugair, A; Alsuhaibani, H; Khalaf, H | 1 |
| Doros, A | 1 |
| Badawi, RD; Chaudhari, AJ; Deutsch, LS; Fisher, J; Garza, AS; Kim, I; Li, CS; Lin, F; Lin, TC; Loh, S; Monsky, WL; Sandhu, P; Sidhar, V | 1 |
| Bernard, SA; Burke, CT; Dixon, RD; Kennedy, AS; Khandani, AH; Mauro, MA; Moore, DT; O'Neil, BH; Stavas, JM; Tsai, AL | 1 |
| Illidge, T; Jeans, S; Laasch, HU; Lawrance, JA; Murphy, G; Omed, A; Tipping, J; Wilson, G; Zivanovic, M | 1 |
| Benassi, M; Carpanese, L; Ettorre, GM; Iaccarino, G; Maini, CL; Pizzi, G; Rea, S; Sciuto, R; Soriani, A; Strigari, L | 1 |
| Merle, P; Mornex, F | 1 |
| Lai, EC; Lau, WY; Leung, TW | 1 |
| Chang, CY; Chao, LS; Huang, PI; Lee, RC; Lin, KH; Liu, CS; Liu, RS; Oliver Wong, CY; Tseng, HS; Tung, CJ; Wang, LW; Wang, SJ; Yen, SH | 1 |
| Coldwell, D; Kennedy, A; Salem, R; Sangro, B; Wasan, H | 3 |
| Kennedy, AS; Kim, YH; Lai, HK; Lau, WY; Lee, RC; Leung, TW; Liu, CS; Salem, R; Sangro, B; Shuter, B; Wang, SC | 1 |
| Antonini, M; Antonucci, G; Carpanese, L; Ettorre, GM; Maini, CL; Miglioresi, L; Puoti, C; Santoro, R; Sciuto, R; Vennarecci, G | 1 |
| Van de Wiele, C | 1 |
| Chen, YY; Soon, MS; Su, WW; Yang, CW; Yen, HH | 1 |
| Antoch, G; Bockisch, A; Cicinnati, VR; Ertle, J; Fouly, AE; Gerken, G; Hamami, M; Heusner, T; Hilgard, P; Müller, S; Paul, A; Scherag, A | 1 |
| Abecassis, M; Atassi, B; Baker, T; Benson, AB; Carr, J; Chen, R; Chrisman, HB; Gates, VL; Gupta, R; Ibrahim, SM; Kulik, L; Lewandowski, RJ; Memon, K; Miller, FH; Mulcahy, MF; Nemcek, AA; Newman, S; Nikolaidis, P; Omary, RA; Resnick, SA; Riaz, A; Ryu, RK; Salem, R; Sato, KT; Senthilnathan, S; Vogelzang, RL; Wang, E; Yaghmai, V | 1 |
| Kee, ST; Lee, EW; Liu, DM; Loh, CT; McWilliams, JP | 1 |
| Chen, YJ; Holt, A; Kim, J; Marx, H; McKenzie, S; Senthil, M; Vora, N; Wagman, LD | 1 |
| Esmail, AA; Gates, VL; Marshall, K; Salem, R; Spies, S | 1 |
| Boucher, E; Edeline, J; Garin, E; Pracht, M; Raoul, JL; Rolland, Y | 1 |
| Choi, BI; Kim, KW; Lee, JM | 1 |
| Sato, KT | 1 |
| Bampo, C; Bhoori, S; Bombardieri, E; Camerini, T; Chiesa, C; Civelli, E; Lanocita, R; Maccauro, M; Marchianò, A; Mazzaferro, V; Morosi, C; Negri, A; Pellizzari, S; Romito, R; Seregni, E; Sposito, C; Spreafico, C | 1 |
| Gadaleta, CD; Goffredo, V; Paradiso, A; Ranieri, G | 1 |
| Becker, CD; Buchegger, F; Garibotto, V; Heinzer, S; Majno, P; Ratib, O; Terraz, S; Viallon, M; Wissmeyer, M; Zaidi, H | 1 |
| Carr, BI; Metes, DM | 1 |
| Geschwind, JF; Lewandowski, RJ; Liapi, E; Salem, R | 1 |
| Gaba, RC; Gundavaram, P | 1 |
| Ahmadzadehfar, H; Bilbao, JI; Cappelli, A; Carpanese, L; Cianni, R; Ettorre, GM; Ezziddin, S; Fiore, F; Gasparini, D; Geatti, O; Giampalma, E; Golfieri, R; Hoffmann, RT; Iñarrairaegui, M; Izzo, F; Jakobs, TF; Lastoria, S; Maini, CL; Paprottka, PM; Salvatori, R; Sangro, B; Urigo, C; Van Buskirk, M; Vit, A; Wilhelm, K | 1 |
| Bain, VG; Liu, DM; Ma, M; Meza-Junco, J; Montano-Loza, AJ; Owen, R; Sawyer, MB | 1 |
| Antoch, G; Herzer, K; Hilgard, P; Müller, S | 1 |
| Loffroy, R | 1 |
| Heiba, S; Jiang, M; Kim, E; Machac, J; Nowakowski, FS; Wang, J; Weintraub, J; Zhang, Z | 1 |
| Defreyne, L; Lambert, B; Mertens, J; Oltenfreiter, R; Smeets, P; Sturm, E; Troisi, R; Van Vlierberghe, H | 1 |
| Bilbao, JI; Iñarrairaegui, M; Sangro, B | 1 |
| Bilgic, S; Kucuk, ON; Lacin, S; Ozkan, E; Soydal, C | 1 |
| Ardisson, V; Boucher, E; Bourguet, P; Clement, B; Garin, E; Laffont, S; Lenoir, L; Mesbah, H; Porée, P; Pracht, M; Rolland, Y | 1 |
| Antoch, G; Bockisch, A; Ertle, J; Gerken, G; Hamami, M; Heusner, TA; Lauenstein, TC; Schlaak, JF | 1 |
| Salem, R | 1 |
| Aucejo, FN; Cheah, G; Kim, R; Lance, C; Levitin, A; McLennan, G; Menon, KV; Obuchowski, N; Sands, M; Shrikanthan, S; Spain, J; Srinivas, S | 1 |
| Garin, E | 1 |
| Ahmadzadehfar, H; Ezziddin, S; Sabet, A; Schäfer, N; Schüller, H; Wilhelm, K | 1 |
| Chalian, H; Galizia, MS; McCarthy, R; Salem, R; Töre, HG; Yaghmai, V | 1 |
| Goh, SW; Kao, YH; Ng, CE; Tan, EH | 1 |
| Dieudonné, A; Gardin, I; Garin, E; Laffont, S; Lebtahi, R; Leguludec, D; Rolland, Y | 1 |
| Abecassis, M; Baker, T; Ibrahim, SM; Kulik, L; Lewandowski, RJ; Mulcahy, MF; Ryu, RK; Salem, R | 1 |
| Wallington, M; Wigg, A | 1 |
| Crocetti, L; Lencioni, R | 1 |
| Boucher, E; Clément, B; Edeline, J; Garin, E; Laffont, S; Lenoir, L; Mesbah, H; Porée, P; Raoul, JL; Rolland, Y | 1 |
| Burgmans, MC; Eng Ng, DC; Gong Lo, RH; Hock Tan, AE; Hoe Chow, PK; Irani, FG; Kao, YH; Khoo, LS; Tan, BS; Tay, KH; Whatt Goh, AS | 1 |
| Liu, Q; Xie, T; Zaidi, H | 1 |
| Benito, A; Bilbao, JI; D'Avola, D; Dominguez, I; Herrero, JI; Iñarrairaegui, M; Martí, P; Pardo, F; Quiroga, J; Rodriguez, M; Rotellar, F; Sangro, B; Zozaya, G | 1 |
| Francis, IR; Krishnamurthy, VN; Novelli, PM; Pandya, A; Vellody, R; Willatt, JM | 1 |
| Gaba, RC; Vanmiddlesworth, KA | 1 |
| Basciano, CA; Childress, EM; Kennedy, AS; Kleinstreuer, C | 1 |
| Difilippo, FP; Levitin, A; McLennan, G; Shrikanthan, S; Spain, J; Srinivas, SM; Wilkinson, A; Xia, P; Yu, N | 1 |
| Bhoori, S; Bombardieri, E; Bongini, M; Camerini, T; Chiesa, C; Civelli, E; Lanocita, R; Maccauro, M; Marchianò, A; Mazzaferro, V; Morosi, C; Romito, R; Sposito, C; Spreafico, C | 1 |
| Al Younis, I; Coenraad, MJ; Defreyne, L; Lam, MG; Lambert, B; Seinstra, BA; van den Bosch, MA; van Erkel, AR; van Erpecum, KJ; van Hoek, B; van Vlierberghe, H; Verkooijen, HM | 1 |
| Buczkowski, A; Ho, S; Klass, D; Kritzinger, J; Lim, H; Liu, D; Yoshida, E | 1 |
| Burgmans, MC; Chow, PK; Dames, EL; Goh, AS; Irani, FG; Kao, YH; Lo, RH; Tay, KH; Teo, TK | 1 |
| Lewandowski, RJ; Memon, K; Riaz, A; Salem, R | 1 |
| Bockisch, A; Ertle, J; Lauenstein, TC; Müller, S; Schlaak, JF; Schlosser, TW; Theysohn, JM | 1 |
| Benson, AB; Ganger, D; Gates, VL; Gupta, R; Kulik, L; Lewandowski, RJ; Memon, K; Miller, FH; Mulcahy, MF; Omary, RA; Riaz, A; Salem, R; Vouche, M | 1 |
| Alberts, SR; Andrews, JC; de Groen, PC; Fleming, CJ; Gansen, DN; Gores, GJ; Harmsen, WS; Harnois, DM; Larusso, NF; Lazaridis, KN; Mettler, TA; Moreno-Luna, LE; Narayanan Menon, KV; Paz-Fumagalli, R; Roberts, LR; Sanchez, W; Slettedahl, SW; Therneau, TM; Wiseman, GA; Yang, JD | 1 |
| Bolondi, L; Piscaglia, F | 1 |
| Geller, JI; Hawkins, CM; Kukreja, K; Ristagno, R; Schatzman, C | 1 |
| Benito, A; Bilbao, JI; Chopitea, A; D'Avola, D; Dominguez, I; Gil-Alzugaray, B; Herrero, JI; Iñarrairaegui, M; Prieto, J; Quiroga, J; Rodriguez, J; Rodriguez-Fraile, M; Sangro, B | 1 |
| Baechler, S; Boubaker, A; Dieudonné, A; Gardin, I; Hobbs, RF; Le Guludec, D; Lebtahi, R; Maurel, F; Sgouros, G; Wahl, RL | 1 |
| Abecassis, MM; Baker, T; Donahue, LA; Ganger, DR; Gupta, R; Kulik, L; Lewandowski, RJ; Memon, K; Salem, R | 1 |
| Goris, ML; Iagaru, AH; Lam, MG; Louie, JD; Sze, DY | 1 |
| Bampo, C; Bhoori, S; Bombardieri, E; Camerini, T; Carrara, M; Chiesa, C; Civelli, E; Lanocita, R; Maccauro, M; Marchianò, A; Mazzaferro, V; Mira, M; Morosi, C; Negri, A; Pellizzari, S; Romito, R; Seregni, E; Sposito, C; Spreafico, C | 1 |
| Buscombe, JR | 1 |
| Carr, BI; Geschwind, JF; Goin, JE; Salem, R; Thurston, KG | 1 |
| Geschwind, JF; Ramsey, DE | 1 |
| Ho, SK; Lau, WY; Leung, TW; Yu, SC | 1 |
| Salto-Tellez, M; Tan, KB; Thamboo, Tp; Wang, SC | 1 |
| Keng, GH; Sundram, FX | 1 |
| Ahlman, H; Bernhardt, P; Forssell-Aronsson, E | 1 |
| Carr, BI | 2 |
| Baum, A; Carr, B; Steel, J | 1 |
| Abouljoud, M; Courtney, A; Goin, J; Lewandowski, R; Roberts, C; Salem, R; Thurston, K | 1 |
| Kennedy, AS; Li, XA; Lodge, MA; Sarfaraz, M; Wu, X; Yu, CX | 1 |
| Carr, BI; Geschwind, JF; Goin, JE; Goin, KA; Roberts, CA; Salem, R; Soulen, MC; Thurston, KG; Van Buskirk, M | 1 |
| Al-Ghazi, MS; Fields, D; Herman, J; Imagawa, DK; Kuo, JV; Liu, MD; Milne, N; Nguyen, TH; Ramsinghani, NS; Tokita, KM; Tsai, FY; Uaje, MB; Vajgrt, DJ | 1 |
| Coldwell, D; Drachenberg, C; Gaiser, J; Kennedy, AS; Nutting, C | 1 |
| Dawson, LA | 1 |
| Carr, BI; Dancey, JE; Geschwind, JF; Goin, JE; Goin, K; Salem, R; Soulen, MC; Thurston, K; Van Buskirk, M | 2 |
| Ahmad, J; Carr, BI; Rhee, J | 1 |
| Bailey, W; Dowling, R; Gibbs, P; Liechtenstein, M; Lim, L; Little, A; Shapiro, JD; Smith, D; Yip, D | 1 |
| Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
| Barakat, O; Gates, V; Gordon, S; Larson, AC; Lewandowski, RJ; Mounajjed, T; Mulcahy, M; Omary, RA; Rhee, TK; Salem, R; Sato, KT | 1 |
| Abecassis, MM; Hunter, RD; Kulik, LM; Mulcahy, MF; Nemcek, AA; Salem, R | 1 |
| Atassi, B; Barakat, O; Gates, VL; Gordon, SC; Lewandowski, RJ; Salem, R; Sergie, Z; Thurston, KG; Wong, CY | 1 |
| Abouljoud, MS; Kim, DY; Kwon, DS; Ma, CK; Salem, R | 1 |
| Deng, J; Kulik, LM; Larson, AC; Miller, FH; Mulcahy, MF; Omary, RA; Rhee, TK; Salem, R; Sato, KT | 1 |
| Benito, A; Bilbao, JI; Boan, J; Gil, B; Herrero, I; Inarrairaegui, M; Martinez-Cuesta, A; Panizo, A; Prieto, J; Quiroga, J; Rodriguez, J; Sangro, B | 1 |
| Salem, R; Thurston, KG | 1 |
| Hunter, RD; Salem, R | 1 |
| Fisher, J; Giap, H; Hillebrand, DJ; Marsh, C; Miller, W; Rivera, L; Schaffer, RL | 1 |
| Abecassis, MM; Atassi, B; Haines, KG; Hunter, RD; Kulik, LM; Lewandowski, RJ; Mulcahy, MF; Nemcek, AA; Salem, R; Souman, T; van Holsbeeck, L | 1 |
| Al-Nahhas, A; Bansi, D; Canelo, R; Habib, N; Jiao, L; Nijran, K; O'Rourke, E; Rubello, D; Stamp, G; Szyszko, T; Tait, P; Thillainayagam, A; Wasan, H | 1 |
| Atassi, B; Gates, VL; Lewandowski, RJ; Nemcek, AA; Omary, R; Ryu, RK; Salem, R; Sato, KT | 1 |
| Bluemke, DA; Geschwind, JF; Kamel, IR; Liapi, E; Reyes, DK | 1 |
| Welsh, JS | 1 |
| Huang, J; Jin, J; Keppke, AL; Larson, AC; Miller, FH; Reddy, D; Salem, R | 1 |
| Hobbelink, MG; Nijsen, JF; van Het Schip, AD; Vente, MA; Zonnenberg, BA | 1 |
| Allison, C | 1 |
| Kulik, LM; Mulcahy, MF; Omary, RA; Salem, R | 1 |
| Helmberger, TK; Hoffmann, RT; Jakobs, TF; Reiser, MF; Tatsch, K; Trumm, C | 1 |
| Dowsett, R; Foster, J; Rowe, BP; Weiner, R | 1 |
| Atassi, B; Gates, VL; Kulik, L; Larson, AC; Lewandowski, RJ; Mulcahy, MF; Omary, RA; Rhee, TK; Ryu, RK; Salem, R; Sato, KT; Young, JY | 1 |
| Abecassis, M; Atassi, B; Benson, A; Carr, BI; Gates, VL; Kulik, LM; Lewandowski, RJ; Mulcahy, MF; Nemcek, AA; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
| Avila-Rodriguez, MA; Converse, AK; Hampel, JA; Jaskowiak, CJ; McDermott, JC; Nickles, RJ; Selwyn, RG; Thomadsen, BR; Warner, TF | 1 |
| Bruix, J; Forner, A | 1 |
| Abdel-Misih, R; Dignazio, M; Garcia, M; Khatri, J; Neff, R; Petrelli, N; Wilson, P | 1 |
| Lai, PB; Lau, WY; Ng, SS; Yu, SC | 1 |
| Gates, VL; Ibrahim, SM; Kulik, L; Lewandowski, RJ; Mulcahy, MF; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
| Al-Nahhas, A; Khodjibekova, M; Rubello, D; Singh, A; Szyszko, T; Tait, P | 1 |
| Lim, LG; Thamboo, TP; Wai, CT; Wang, SC | 1 |
| Atassi, B; Bangash, AK; Ibrahim, S; Kulik, L; Lewandowski, RJ; Miller, FH; Mulcahy, MF; Murthy, R; Omary, RA; Ryu, RK; Salem, R; Sato, KT | 1 |
| Chan, MS; Chow, JH; Ho, SK; Johnson, PJ; Lau, WY; Leung, TW; Li, AK; Metreweli, C; Ward, SC | 1 |
| Chan, M; Ho, S; Johnson, P; Lau, WY; Leung, NW; Leung, WT; Li, AK; Lin, J; Metreweli, C | 1 |
| Baer, HU; Geiger, L; Rösler, H; Triller, J | 1 |
| Dong, BW; Jing, XH; Liang, P | 1 |
| Baer, HU; Becker, C; Beer, HF; Blumgart, LH; Geiger, L; Rösler, H; Triller, J | 1 |
| Lin, M | 1 |
| Dong, BW; Liang, P; Tian, JH; Wang, XD; Xu, BX; Zhang, JM | 1 |
| Chan, M; Ho, S; Johnson, PJ; Lau, WY; Leung, TW; Li, AK; Ngar, YK | 1 |
| Chan, M; Ho, S; Johnson, PJ; Lau, WY; Leung, TW; Li, AK | 1 |
| Chan, KW; Chan, M; Ho, S; Johnson, PJ; Lau, WY; Lee, WY; Leung, TW; Li, AK | 1 |
| Chan, M; Ho, R; Ho, S; Johnson, PJ; Lau, WY; Leung, TW; Li, AK | 1 |
| Dancey, JE; Gabrys, J; Goin, JE; Hendler, AL; Houle, S; Paul, K; Shepherd, FA; Sniderman, KW | 1 |
| Buscombe, JR; Padhy, A | 1 |
| Chen, SD; Cheng, KY; Hsieh, JF; Lin, WY; Tsai, SC; Wang, SJ | 1 |
| Ho, S; Lau, JW; Leung, TW | 1 |
| Cao, X; He, N; Li, J; Lu, T; Sun, J; Tan, J; Yang, J; Zhang, C | 1 |
| Ho, S; Johnson, PJ; Lau, WY; Leung, WT | 1 |
| Leung, CB; Leung, TW; Li, PK; Lui, SF; Szeto, CC; Wang, AY; Wong, TY | 1 |
| Georgiades, CS; Geschwind, JF; Ramsey, DE; Solomon, S | 1 |
| Ho, S; Lau, WY; Leung, WT | 1 |
| Chen, H; Chen, W; Chen, Y; Huang, C; Huang, J; Shen, J; Yang, F; Yang, W | 1 |
| Htoo, MM; Keng, GH; Kwok, R; Oon, CJ; Premaraj, J; Somanesan, S; Sundram, FX; Yu, SW | 1 |
| Crumbley, AJ; Grady, ED; Nolan, TR; Rosen, AR | 1 |
| Grady, ED | 1 |
| Houle, S; Paul, K; Rotstein, LE; Shepherd, FA; Sniderman, KW; Yip, TC | 1 |
| Hilson, A; Hobbs, KE; Novell, JR | 1 |
| Hawkins, WG; Klein, JL; Leichner, PK; Order, SE; Wessels, BW; Yang, NC | 1 |
| Dillehay, LE; Williams, JR | 1 |
| Order, SE; Sitzmann, JV | 1 |
| Cawthorn, RH; Houle, S; Richmond-Cox, K; Rotstein, LE; Shepherd, FA; Sniderman, KW; Theis, E; Yip, TK | 1 |
| Dillehay, LE; Frincke, J; Klein, JL; Kopher, KA; Laroque, P; Leichner, PK; Nguyen, TH; Order, SE; Wessels, BW; Williams, JR | 1 |
| Frenkel, TL; Hawkins, WG; Klein, JL; Leichner, PK; Loudenslager, DM; Order, SE; Yang, NC | 1 |
| Carlo, DJ; Frincke, J; Klein, JL; Leichner, PK; Lollo, C; Order, SE | 1 |
127 review(s) available for yttrium radioisotopes and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Liver resection after Y-90 radioembolization: a systematic review and meta-analysis of perioperative morbidity and mortality.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Morbidity; Yttrium Radioisotopes | 2022 |
Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer - a systematic review and network meta-analysis of survival data.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Network Meta-Analysis; Radiofrequency Ablation; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Pneumonectomy; Yttrium Radioisotopes | 2022 |
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors.
Topics: Carcinoma, Hepatocellular; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Liver Neoplasms; Melanoma; Yttrium Radioisotopes | 2022 |
Role of Interventional Radiology in Pediatric Cancer Patients.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Child; Humans; Liver Neoplasms; Radiology, Interventional | 2022 |
Yttrium-90 Radioembolization: Current Indications and Outcomes.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Advances in Radiation Therapy for Primary Liver Cancer.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Radiosurgery; Yttrium Radioisotopes | 2023 |
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.
Topics: Ablation Techniques; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiosurgery; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2020 |
NEMESIS: Noninferiority, Individual-Patient Metaanalysis of Selective Internal Radiation Therapy with
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Sorafenib; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Liver Transplantation; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Yttrium Radioisotopes | 2020 |
A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials.
Topics: Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Progression-Free Survival; Randomized Controlled Trials as Topic; Survival Rate; Yttrium Radioisotopes | 2021 |
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2020 |
Hybrid angiography-CT for transarterial radioembolization: a pictorial essay.
Topics: Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Odds Ratio; Progression-Free Survival; Survival Analysis; Yttrium Radioisotopes | 2021 |
Management of hepatocellular in the United States.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Embolization, Therapeutic; Europe; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Treatment Outcome; United States; Yttrium Radioisotopes | 2017 |
Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Topics: Antineoplastic Agents, Immunological; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Clinical Trials as Topic; Combined Modality Therapy; Humans; Liver Neoplasms; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Practice Guidelines as Topic; Proton Therapy; Radiosurgery; Radiotherapy; Sorafenib; Survival Rate; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2017 |
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase III as Topic; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2017 |
Radioembolisation of hepatocellular carcinoma: a primer.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2017 |
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Panitumumab; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques.
Topics: Angiography; Carcinoma, Hepatocellular; Education, Medical, Continuing; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Nuclear Medicine; Radiopharmaceuticals; Radiotherapy Dosage; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Whole Body Imaging; Yttrium Radioisotopes | 2018 |
Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Organ Specificity; Patient Selection; Radiation Injuries; Radiobiology; Radiology, Interventional; Yttrium Radioisotopes | 2019 |
Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Liver Neoplasms; Microspheres; Patient Selection; Radiography, Interventional; Radiotherapy Dosage; Yttrium Radioisotopes | 2019 |
Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Lung; Outcome and Process Assessment, Health Care; Patient Selection; Radiography, Interventional; Radiotherapy Dosage; Yttrium Radioisotopes | 2019 |
Yttrium-90 Complications: Prevention and Management.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Portasystemic Shunt, Transjugular Intrahepatic; Radiation Injuries; Radiography, Interventional; Yttrium Radioisotopes | 2019 |
[Nuclear medicine techniques for selective internal radiotherapy of liver cancer].
Topics: Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2017 |
Comparison of the Adverse Event Profile of TheraSphere
Topics: Adult; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Yttrium Radioisotopes | 2017 |
Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Yttrium Radioisotopes | 2022 |
Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLC.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Staging; Retrospective Studies; Yttrium Radioisotopes | 2022 |
[Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Patient Selection; Technetium Tc 99m Aggregated Albumin; Treatment Outcome; Yttrium Radioisotopes | 2022 |
The Role of Catheter-Directed CT-Angiography in Radioembolisation.
Topics: Angiography; Carcinoma, Hepatocellular; Catheters; Computed Tomography Angiography; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2022 |
SIRT in 2025.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
Trans-arterial Radioembolization Dosimetry in 2022.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiometry; Yttrium Radioisotopes | 2022 |
Transarterial Radioembolization for Hepatic Metastases of Pancreatic Adenocarcinoma: A Systematic Review.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Embolization, Therapeutic; Humans; Liver Neoplasms; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Radiometry; Yttrium Radioisotopes | 2023 |
Cancer Immunology: Impact of Radioembolization of Hepatocellular Carcinoma on Immune Response Modulation.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Immunity; Liver Neoplasms; Tumor Microenvironment; Yttrium Radioisotopes | 2023 |
Complications Related to Transarterial Treatment of Hepatocellular Carcinoma: A Comprehensive Review.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Evolution of Personalized Dosimetry for Radioembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiometry; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Radioembolization for Treatment of Hepatocellular Carcinoma: Current Evidence and Patterns of Utilization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2023 |
The Unique Role of Fluorodeoxyglucose-PET in Radioembolization.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2019 |
[Interventional radiology of liver tumors].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Hepatectomy; Hepatic Artery; Humans; Liver Neoplasms; Portal System; Radiology, Interventional; Yttrium Radioisotopes | 2019 |
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Functional Status; Humans; Infusions, Intra-Arterial; Liver Function Tests; Liver Neoplasms; Microspheres; Neoplasm Staging; Radiosurgery; Tumor Burden; Yttrium Radioisotopes | 2020 |
Selective internal radiation therapy in the management of primary and metastatic disease in the liver.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2021 |
To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Yttrium Radioisotopes | 2021 |
Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Update on Embolization Therapies for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2017 |
Radioembolization for the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver; Liver Neoplasms; Mastectomy, Segmental; Neoplasm Recurrence, Local; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
Imaging of Hepatocellular Carcinoma Response After
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2018 |
Transarterial Radioembolization (TARE) Agents beyond
Topics: Animals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials as Topic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2018 |
Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Drug Carriers; Humans; Liver Neoplasms; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Sorafenib; Survival Rate; Yttrium Radioisotopes | 2013 |
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials as Topic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Yttrium Radioisotopes | 2013 |
Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Humans; Ischemia; Liver Neoplasms; Necrosis; Portal Vein; Prognosis; Quality of Life; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |
90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Comparative Effectiveness Research; Cost-Benefit Analysis; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Prospective Studies; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2013 |
The role of SPECT/CT in radioembolization of liver tumours.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Multimodal Imaging; Radiation Dosage; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
Treatment of intermediate-stage hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2014 |
Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Quality of Life; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Clinical studies in hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoradiotherapy; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2014 |
How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver; Liver Neoplasms; Radiography, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Locoregional therapy of hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cryosurgery; Electrochemotherapy; Ethanol; Humans; Injections, Intralesional; Liver Neoplasms; Microwaves; Yttrium Radioisotopes | 2015 |
⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Multimodal Imaging; Radiometry; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2015 |
(90)Y-glass microspheres for hepatic neoplasia.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Diffusion of Innovation; Embolization, Therapeutic; Female; Forecasting; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Niacinamide; Patient Selection; Phenylurea Compounds; Radiopharmaceuticals; Sorafenib; Yttrium Radioisotopes | 2015 |
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
Topics: Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver; Liver Neoplasms; Lung; Maximum Tolerated Dose; Microspheres; Monte Carlo Method; Neoplasm Metastasis; Radiometry; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2015 |
Trans-Arterial Radioembolization for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials as Topic; Humans; Liver Neoplasms; Microspheres; Microvessels; Neoplasm Staging; Yttrium Radioisotopes | 2015 |
Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Length of Stay; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Catheter-based transarterial therapies for hepatocellular cancer.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Embolization, Therapeutic; Humans; Liver Neoplasms; Mitomycin; Postoperative Care; Postoperative Complications; Radiotherapy; Yttrium Radioisotopes | 2015 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Patient Selection; Radiometry; Yttrium Radioisotopes | 2016 |
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Randomized Controlled Trials as Topic; Sorafenib; Yttrium Radioisotopes | 2016 |
Current role of selective internal radiation with yttrium-90 in liver tumors.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Prospective Studies; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Retrospective Studies; Yttrium Radioisotopes | 2016 |
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Management; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Staging; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2016 |
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials as Topic; Disease Progression; Female; Humans; Liver Neoplasms; Male; Patient Selection; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2016 |
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Chemoradiotherapy; Disease Progression; Humans; Liver Failure; Liver Neoplasms; Neoplasm Staging; Observational Studies as Topic; Portal Vein; Survival Rate; Time Factors; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Embolization, Therapeutic; Humans; Liver Neoplasms; Prospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Radioembolization-induced liver disease: a systematic review.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Diseases; Liver Neoplasms; Microspheres; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Yttrium Radioisotopes | 2017 |
Contemporary management of hepatocellular carcinoma.
Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Hepatectomy; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Liver Transplantation; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Receptors, Vascular Endothelial Growth Factor; Risk Factors; Sorafenib; Yttrium Radioisotopes | 2008 |
[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Topics: Algorithms; Brachytherapy; Carcinoma, Hepatocellular; Diagnostic Imaging; Embolization, Therapeutic; Humans; Iodine Radioisotopes; Iodized Oil; Liver Function Tests; Liver Neoplasms; Microspheres; Neovascularization, Pathologic; Radiation Tolerance; Radioisotopes; Radiotherapy Dosage; Rhenium; Yttrium Radioisotopes | 2009 |
Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes | 2009 |
Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors.
Topics: Carcinoma, Hepatocellular; Drug Carriers; Humans; Liver Neoplasms; Microspheres; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Resins, Synthetic; Yttrium Radioisotopes | 2009 |
Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2009 |
Liver transplantation after radioembolization in a patient with unresectable HCC.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Yttrium Radioisotopes | 2009 |
State of the art: radiolabeled microspheres treatment for liver malignancies.
Topics: Carcinoma, Hepatocellular; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Radiation-Sensitizing Agents; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2010 |
[Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Topics: Angiography; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Film Dosimetry; Glass; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Neoplasm Staging; Radiation Injuries; Radiation Protection; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Resins, Synthetic; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2010 |
[Interventional radiological treatment of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Disease Progression; Humans; Liver Neoplasms; Microspheres; Radiology, Interventional; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2010 |
[Nonsurgical management of hepatocellular carcinoma].
Topics: Angiogenesis Inhibitors; Benzenesulfonates; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Drug Delivery Systems; Humans; Liver Neoplasms; Neoplasm Invasiveness; Niacinamide; Phenylurea Compounds; Portal Vein; Pyridines; Radiotherapy, Conformal; Sorafenib; Yttrium Radioisotopes | 2010 |
Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review.
Topics: Carcinoma, Hepatocellular; Cohort Studies; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Microspheres; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Yttrium Radioisotopes | 2011 |
Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Survival Rate; Yttrium Radioisotopes | 2012 |
Radioembolization of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Ethiodized Oil; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Survival; Yttrium Radioisotopes | 2010 |
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Glass; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Microspheres; Resins, Synthetic; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2012 |
[Radioembolisation for hepatocellular carcinoma].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Ethiodized Oil; Humans; Liver Neoplasms; Microspheres; Radioisotopes; Rhenium; Yttrium Radioisotopes | 2011 |
Assessment of the treatment response of HCC.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Contrast Media; Ethanol; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors.
Topics: Carcinoma, Hepatocellular; Humans; Liver; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2011 |
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
Topics: Academies and Institutes; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Humans; Italy; Liver; Liver Neoplasms; Microspheres; Models, Biological; Radiation Pneumonitis; Radiobiology; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes | 2011 |
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009).
Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Clinical Trials as Topic; Embolization, Therapeutic; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neuroendocrine Tumors; Radioimmunotherapy; Receptors, Peptide; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Transcatheter intraarterial therapies: rationale and overview.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Yttrium Radioisotopes | 2011 |
Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
Topics: Ablation Techniques; Antineoplastic Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Randomized Controlled Trials as Topic; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
Topics: Algorithms; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Mathematical Computing; Microspheres; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Interventional radiology for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cryosurgery; Evidence-Based Medicine; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Liver Neoplasms; Radiology, Interventional; Radiotherapy Dosage; Yttrium Radioisotopes | 2011 |
Radioembolization for hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiobiology; Radiotherapy Dosage; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Local-regional treatment of hepatocellular carcinoma.
Topics: Ablation Techniques; Algorithms; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Electroporation; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Microwaves; Neoplasm Staging; Radiofrequency Therapy; Radiography, Interventional; Radiotherapy, Image-Guided; Survival Rate; Yttrium Radioisotopes | 2012 |
Radioembolization for the treatment of liver tumors general principles.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Patient Selection; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Interventional therapies for hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Contraindications; Drug Implants; Ethanol; Ethiodized Oil; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging, Interventional; Microspheres; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiography, Interventional; Randomized Controlled Trials as Topic; Retrospective Studies; Sclerotherapy; Yttrium Radioisotopes | 2012 |
Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Emulsions; Equipment Design; Ethiodized Oil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Neovascularization, Pathologic; Radiography, Interventional; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Microspheres; Patient Selection; Radiopharmaceuticals; Yttrium Radioisotopes | 2013 |
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials as Topic; Humans; Liver; Liver Neoplasms; Microspheres; Neoplasm Staging; Radiotherapy Dosage; Yttrium Radioisotopes | 2002 |
New interventions for liver tumors.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Ethanol; Humans; Infusions, Intra-Arterial; Laser Coagulation; Liver Neoplasms; Microspheres; Microwaves; Radiography, Interventional; Ultrasonic Therapy; Yttrium Radioisotopes | 2002 |
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications; Cryosurgery; Ethanol; Hepatectomy; Humans; Injections, Intralesional; Laser Coagulation; Liver Neoplasms; Microspheres; Microwaves; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2003 |
Radionuclide therapy of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Liver Neoplasms; Male; Neoplasm Staging; Palliative Care; Prognosis; Radiotherapy, Adjuvant; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2003 |
Hepatocellular carcinoma: current management and future trends.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Microspheres; Neoplasm Staging; Patient Selection; Prognosis; Survival Analysis; Yttrium Radioisotopes | 2004 |
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Topics: Algorithms; Autopsy; Biopsy; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Colonic Neoplasms; Colorectal Neoplasms; Female; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Radiotherapy Dosage; Yttrium Radioisotopes | 2004 |
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
Topics: Angiography; Brachytherapy; Carcinoma, Hepatocellular; Disease Management; Embolization, Therapeutic; Humans; Liver Neoplasms; Mesentery; Microspheres; Patient Care Team; Patient Selection; Practice Guidelines as Topic; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Splanchnic Circulation; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2006 |
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiotherapy Dosage; Yttrium Radioisotopes | 2006 |
Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
Topics: Carcinoma, Hepatocellular; Contraindications; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Neoplasm Metastasis; Radiation Injuries; Yttrium Radioisotopes | 2007 |
Radionuclide liver cancer therapies: from concept to current clinical status.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Delivery Systems; Holmium; Humans; Iodine Radioisotopes; Liver; Liver Neoplasms; Microspheres; Prognosis; Radiopharmaceuticals; Rhenium; Yttrium Radioisotopes | 2007 |
Emerging approaches in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Combined Modality Therapy; Embolization, Therapeutic; Hepatectomy; Humans; Liver Transplantation; Patient Selection; Yttrium Radioisotopes | 2007 |
[Developments and perspectives in radioablative techniques].
Topics: Antineoplastic Agents; Brachytherapy; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Microspheres; Neoplasms; Radiation-Sensitizing Agents; Radiography; Radiology, Interventional; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2007 |
Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Rhenium; Treatment Outcome; Yttrium Radioisotopes | 2008 |
New nonsurgical therapies in the treatment of hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Infusions, Intra-Arterial; Laser Coagulation; Liver Neoplasms; Patient Selection; Survival Rate; Ultrasonography; Yttrium Radioisotopes | 2001 |
Therapeutic aspects of radio-isotopes in hepatobiliary malignancy.
Topics: Antibodies; Brachytherapy; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Iodized Oil; Iridium Radioisotopes; Liver Neoplasms; Prognosis; Radiotherapy Dosage; Yttrium Radioisotopes | 1991 |
Radiobiology of dose-rate patterns achievable in radioimmunoglobulin therapy.
Topics: Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Humans; Immunization, Passive; Liver Neoplasms; Neoplasms; Yttrium Radioisotopes | 1990 |
Immunoradiotherapy for primary nonresectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Ferritins; Humans; Immunoglobulin G; Iodine Radioisotopes; Liver Neoplasms; Yttrium Radioisotopes | 1989 |
50 trial(s) available for yttrium radioisotopes and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
Topics: Administration, Intravenous; Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Male; Microspheres; Middle Aged; Nivolumab; Progression-Free Survival; Safety; Severity of Illness Index; Singapore; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in Fra
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Quality of Life; Registries; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2022 |
A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
Topics: Ablation Techniques; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Palliative Care; Research Design; Sorafenib; Yttrium Radioisotopes | 2019 |
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Topics: Angiography; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Progression-Free Survival; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cost-Benefit Analysis; Humans; Liver Neoplasms; Microspheres; Quality of Life; Sorafenib; Yttrium Radioisotopes | 2021 |
Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.
Topics: Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Radiotherapy Dosage; Sorafenib; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Portal Vein; Quality of Life; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2018 |
Safety and Efficacy of
Topics: Ascites; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Quality of Life; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Positron Emission Tomography Computed Tomography; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc study.
Topics: Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Patient Selection; Prognosis; Sorafenib; Survival Rate; Tumor Burden; Yttrium Radioisotopes | 2020 |
Fluoroscopic Radiation Exposure in Chemoembolization and Radioembolization: Results from a Prospective Randomized Study.
Topics: Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluoroscopy; Humans; Liver Neoplasms; Male; Microspheres; Prospective Studies; Radiation Exposure; Treatment Outcome; Yttrium Radioisotopes | 2017 |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Sorafenib; Yttrium Radioisotopes | 2018 |
Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib.
Topics: Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Niacinamide; Phenylurea Compounds; Prospective Studies; Sorafenib; Technetium Tc 99m Aggregated Albumin; World Health Organization; Yttrium Radioisotopes | 2013 |
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2013 |
Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Republic of Korea; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Drug Stability; Female; Follow-Up Studies; Glass; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Disease Progression; Dose-Response Relationship, Drug; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Quality of Life; Sorafenib; Time Factors; Yttrium Radioisotopes | 2014 |
Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Early Detection of Cancer; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Graft Rejection; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pilot Projects; Prospective Studies; Radiation Dosage; Sorafenib; Yttrium Radioisotopes | 2014 |
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Protocols; Cost-Benefit Analysis; Disease Progression; Disease-Free Survival; Drug Costs; Embolization, Therapeutic; France; Humans; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Prospective Studies; Protein Kinase Inhibitors; Quality of Life; Research Design; Sorafenib; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Prognosis; Prospective Studies; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
Topics: Absorption, Radiation; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Hepatic Veins; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Organs at Risk; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib.
Topics: Aged; Angiogenesis Inhibitors; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chicago; Down-Regulation; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pilot Projects; Platelet-Derived Growth Factor; Prospective Studies; Radiopharmaceuticals; Sorafenib; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diarrhea; Disease Progression; Disease-Free Survival; Ethiodized Oil; Female; Humans; Hypoalbuminemia; Intention to Treat Analysis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Necrosis; Neoplasm Staging; Prospective Studies; Survival Rate; Yttrium Radioisotopes | 2016 |
Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Prognosis; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2008 |
Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Dose-Response Relationship, Radiation; Female; Hepatic Artery; Humans; Incidence; Liver Neoplasms; Lung; Male; Middle Aged; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2008 |
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Venous Thrombosis; Yttrium Radioisotopes | 2009 |
SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Subtraction Technique; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Retrospective Studies; Severity of Illness Index; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Disease Progression; Embolization, Therapeutic; Health Care Costs; Hepatic Artery; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Netherlands; Quality of Life; Radiography; Radiopharmaceuticals; Research Design; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Yttrium-90 radioembolization for the treatment of unresectable hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Cisplatin; Female; Health Status; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Quality of Life; Survival Analysis; Yttrium Radioisotopes | 2004 |
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Cause of Death; Female; Follow-Up Studies; Forecasting; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Microspheres; Neoadjuvant Therapy; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.
Topics: Aged; Bilirubin; Brachytherapy; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Yttrium Radioisotopes | 2005 |
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.
Topics: Adenocarcinoma; Aged; Australia; Carcinoma, Hepatocellular; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Topics: Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Prospective Studies; Radiography, Interventional; Radiotherapy Dosage; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Illinois; Liver Neoplasms; Male; Microspheres; Middle Aged; Necrosis; Radiographic Image Interpretation, Computer-Assisted; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Body Burden; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Female; Humans; Liver Diseases; Liver Neoplasms; Male; Maximum Allowable Concentration; Middle Aged; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes | 2007 |
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Middle Aged; Portal Vein; Treatment Outcome; United States; Venous Thrombosis; Yttrium Radioisotopes | 2008 |
Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Yttrium Radioisotopes | 1994 |
[Combined treatment of hepatic carcinoma: percutaneous intratumoral injection of Y-90 glass treatment microspheres with sonographic guidance].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Female; Humans; Injections, Intralesional; Liver Neoplasms; Male; Microspheres; Middle Aged; Ultrasonography, Doppler, Color; Ultrasonography, Interventional; Yttrium Radioisotopes | 1994 |
Superselective radioembolization of hepatocellular carcinoma: 5-year results of a prospective study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Quality of Life; Radionuclide Imaging; Survival Rate; Technetium Tc 99m Aggregated Albumin; Time Factors; Yttrium Radioisotopes | 1994 |
Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Follow-Up Studies; Hepatectomy; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Microspheres; Neoplasm Staging; Palliative Care; Postoperative Care; Prognosis; Radioisotopes; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rhenium; Singapore; Treatment Outcome; Yttrium Radioisotopes | 2002 |
A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiotherapy Dosage; Remission Induction; Yttrium Radioisotopes | 1992 |
459 other study(ies) available for yttrium radioisotopes and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Key Role of Personalized Dosimetry in Dose Adjustment for Selective Internal Radiotherapy: Retrospective Study of Patients Treated With 90Y Resin Microspheres.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium-90 Radioembolization: Pipe Dream or Reality?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Portal Vein; Thrombosis; Yttrium Radioisotopes | 2021 |
Combining systemic and local therapies for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Liver Neoplasms; Microspheres; Nivolumab; Prospective Studies; Safety; Treatment Outcome; Yttrium Radioisotopes | 2021 |
The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Consensus; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pharmaceutical Preparations; Quality of Life; Treatment Outcome; Turkey; Yttrium Radioisotopes | 2021 |
Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres.
Topics: Carcinoma, Hepatocellular; Catheters; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Positron Emission Tomography Computed Tomography; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2021 |
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Tumor Microenvironment; Yttrium Radioisotopes | 2022 |
Clinical and prognostic significance of CD14 (+) HLA-DR (-/low) myeloid-derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium-90.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Case-Control Studies; Embolization, Therapeutic; Female; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Liver Neoplasms; Male; Middle Aged; Myeloid Cells; Myeloid-Derived Suppressor Cells; Prognosis; Prospective Studies; Survival Analysis; T-Lymphocytes; Yttrium Radioisotopes | 2022 |
Diagnosis of Pulmonary Embolism on 99mTc-Labeled Macroaggregated Albumin Lung Imaging After Hepatic Arterial Injection for Planning of Radioembolization.
Topics: Albumins; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Pulmonary Embolism; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2022 |
Trans-Arterial Radioembolization with Yttrium-90 of Unresectable and Systemic Chemotherapy Resistant Hepatoblastoma in Three Toddlers.
Topics: Carcinoma, Hepatocellular; Child, Preschool; Embolization, Therapeutic; Hepatoblastoma; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
Yttrium-90 (Y-90) resin microsphere therapy for patients with unresectable hepatocellular carcinoma. Identification of successful treatment response predictors and patient selection.
Topics: Carcinoma, Hepatocellular; Child; Humans; Liver Neoplasms; Microspheres; Patient Selection; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Patient Selection; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Quality of Life; Sorafenib; Yttrium Radioisotopes | 2022 |
The Impact of Injection Distance to Bifurcations on Yttrium-90 Distribution in Liver Cancer Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2022 |
Perspectives for yttrium-90 radioembolization as therapeutic option for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Yttrium-90 radioembolization-induced abscopal effect on hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2022 |
A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall?
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Thrombosis; Umbilical Veins; Venous Thrombosis; Yttrium Radioisotopes | 2022 |
Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
Topics: Carcinoma, Hepatocellular; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Necrosis; Retrospective Studies; Yttrium Radioisotopes | 2022 |
Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden; Yttrium Radioisotopes | 2022 |
Gastrointestinal Tract Injury by Yttrium-90 Appears Largely Restricted to Resin Microspheres But Can Occur Years After Embolization.
Topics: Carcinoma, Hepatocellular; Gastrointestinal Tract; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2022 |
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Hyperbilirubinemia; Liver Neoplasms; Microspheres; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Can pretreatment hepatic artery perfusion scintigraphy in patients with liver malignancies predict the treatment response of the selective internal radiation therapy with 90Y resin microspheres?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2022 |
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2022 |
Yttrium-90 Radioembolization for Liver-Dominant Metastatic Prostate Cancer: A Case Series.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Yttrium Radioisotopes | 2022 |
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Yttrium Radioisotopes | 2023 |
Effect of preoperative liver-directed therapy prior to hepatic resection.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Failure; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Lung shunt fraction calculations before Y-90 transarterial radioembolization: Comparison of accuracy and clinical significance of planar scintigraphy and SPECT/CT.
Topics: Aged; Carcinoma, Hepatocellular; Clinical Relevance; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung; Male; Microspheres; Middle Aged; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2023 |
Temporary Vascular Occlusion with Retrievable Microvascular Plugs to Protect Normal Liver during Yttrium-90 Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
The value of radioembolisation therapy on metastatic liver tumours - a single centre experience.
Topics: Albumins; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Microspheres; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2023 |
Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Pneumonectomy; Retrospective Studies | 2023 |
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Europe; Humans; Liver Neoplasms; Microspheres; Quality of Life; Yttrium Radioisotopes | 2023 |
Authors' Reply: Short- and Long-Term Outcomes for Resin-Based Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma Should Be Further Investigated.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Pneumonectomy; Yttrium Radioisotopes | 2023 |
Early Prediction of Response of Hepatocellular Carcinoma to Yttrium-90 Radiation Segmentectomy Using a Machine Learning MR Imaging Radiomic Approach.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Machine Learning; Magnetic Resonance Imaging; Pneumonectomy; Retrospective Studies | 2023 |
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Necrosis; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Retrospective Studies; Yttrium Radioisotopes | 2023 |
Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement.
Topics: Capecitabine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Portal Vein; Retrospective Studies | 2023 |
Effect of Previous Transarterial Chemoembolization on Survival and Toxicity after Yttrium-90 Transarterial Radioembolization of Hepatocellular Carcinoma in the Radiation-Emitting SIR-Spheres in Nonresectable Liver Tumor Registry.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Prospective Studies; Registries; Retrospective Studies; Treatment Outcome | 2023 |
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Prospective Studies; Yttrium Radioisotopes | 2023 |
Yttrium-90 selective internal radiation therapy, examining dose rates and radiation protection precautions.
Topics: Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Humans; Infant; Liver Neoplasms; Male; Radiation Dosage; Radiation Protection; Radiotherapy Dosage; Yttrium Radioisotopes | 2019 |
PET-CT post therapy dosimetry in radioembolization with resin
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Radiometry; Radiotherapy Dosage; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2019 |
Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
Topics: Albumins; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Dose Fractionation, Radiation; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Organs at Risk; Prognosis; Radiosurgery; Response Evaluation Criteria in Solid Tumors; Safety; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies.
Topics: Aged; Biological Transport; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung; Male; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2019 |
Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
Topics: Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Cohort Studies; Cone-Beam Computed Tomography; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2020 |
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2019 |
Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2020 |
Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™).
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; End Stage Liver Disease; Humans; Liver Neoplasms; Microspheres; Severity of Illness Index; Yttrium Radioisotopes | 2020 |
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Costs and Cost Analysis; Disease Progression; Europe; Health Expenditures; Health Resources; Humans; Liver Neoplasms; Markov Chains; Microspheres; Models, Econometric; Neoplasm Staging; Patient Acceptance of Health Care; Protein Kinase Inhibitors; Yttrium Radioisotopes | 2020 |
Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Middle Aged; Yttrium Radioisotopes | 2020 |
Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Prognosis; Retrospective Studies; Sarcopenia; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Disease Progression; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2020 |
Streamlining TARE or personalizing SIRT? Different philosophies to treat different HCCs with Yttrium-90….
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung; Yttrium Radioisotopes | 2020 |
Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Survival Analysis; Yttrium Radioisotopes | 2021 |
Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report.
Topics: Carcinoma, Hepatocellular; Hepatitis B; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Pulmonary Diffusing Capacity; Radiation Pneumonitis; Yttrium Radioisotopes | 2020 |
Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Liver Neoplasms; Rabbits; Tumor Hypoxia; Yttrium Radioisotopes | 2021 |
Multiscale Computational Fluid Dynamics Modeling for Personalized Liver Cancer Radioembolization Dosimetry.
Topics: Carcinoma, Hepatocellular; Humans; Hydrodynamics; Liver Neoplasms; Radiometry; Yttrium Radioisotopes | 2021 |
Tumor Radiation-absorbed Dose: The Missing Link in Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2020 |
Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Digestive System Fistula; Embolization, Therapeutic; Gastric Fistula; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Yttrium Radioisotopes | 2021 |
SBRT, TACE, TARE, or Combined? in the Treatment of Hepatocellular Cancer.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Drug Delivery Systems; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Radiosurgery; Risk Assessment; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres.
Topics: Carcinoma, Hepatocellular; Cytokines; Hepatitis; Humans; Liver Neoplasms; Microspheres; Treatment Outcome; Tumor Microenvironment; Yttrium Radioisotopes | 2021 |
Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Organs at Risk; Radionuclide Imaging; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2021 |
Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Response assessment of hepatocellular carcinoma treated with yttrium-90 radioembolization: inter-reader variability, comparison with 3D quantitative approach, and role in the prediction of clinical outcomes.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma with Portal Vein Invasion: Validation of the Milan Prognostic Score.
Topics: Aged; Carcinoma, Hepatocellular; Clinical Decision Rules; Clinical Decision-Making; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Patient Selection; Portal Vein; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Benign Biliary Stricture after Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Cholestasis; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Transarterial Yttrium-90 Radioembolization of Hepatocellular Carcinoma Perfused by the Cystic Artery: Multi-institutional Feasibility Study.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Feasibility Studies; Female; Gallbladder; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; United States; Yttrium Radioisotopes | 2020 |
Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Health Care Costs; Humans; Liver; Liver Neoplasms; Microspheres; Patient Selection; Quality of Life; Quality-Adjusted Life Years; Sorafenib; Survival Analysis; Tumor Burden; United Kingdom; Yttrium Radioisotopes | 2021 |
Dose-response for yttrium-90 resin microsphere radioembolisation.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiation Dosage; Radiotherapy Dosage; Resins, Synthetic; Yttrium Radioisotopes | 2021 |
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoradiotherapy; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
Topics: Aged; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Prognosis; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2020 |
Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Humans; Liver Neoplasms; Medicare; Quality of Life; Sorafenib; United States; Yttrium Radioisotopes | 2021 |
Computed tomographic perfusion imaging for the prediction of response transarterial radioembolization with Yttrium‑90 glass microspheres of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Perfusion Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2021 |
A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
Topics: Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Catheterization, Peripheral; Female; Humans; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Republic of Korea; Research Design; Survival Analysis; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2022 |
Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response.
Topics: Ablation Techniques; Aged; Biopsy; Carcinoma, Hepatocellular; Chemoradiotherapy, Adjuvant; Hepatectomy; Humans; Immune Checkpoint Inhibitors; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Nivolumab; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Yttrium-90 radiation lobectomy for initially unresectable hepatocellular carcinoma: A treatment paradigm shift?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2021 |
A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Hypertrophy; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; New York City; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Middle Aged; Neoadjuvant Therapy; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2021 |
Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma.
Topics: Adolescent; Carcinoma, Hepatocellular; Child; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Prognosis; Yttrium Radioisotopes | 2021 |
Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysis.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Middle Aged; Pneumonectomy; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete Response.
Topics: Aged; Area Under Curve; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiation Dosage; User-Computer Interface; Yttrium Radioisotopes | 2021 |
Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
MRI-Derived Sarcopenia Associated with Increased Mortality Following Yttrium-90 Radioembolization of Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Sarcopenia; Yttrium Radioisotopes | 2021 |
Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial Experiences.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Pilot Projects; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Yttrium Radioisotopes | 2021 |
Selective Internal Radiation Therapy Approval for Early HCC: What Comes Next?
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Metformin; Pneumonectomy; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
[Chinese expert consensus on selective internal radiation therapy with yttrium-90 for primary and metastatic hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; China; Consensus; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2021 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiopharmaceuticals; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Liver Neoplasms; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2017 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation: Reply.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Radiopharmaceuticals; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Yttrium Radioisotopes | 2017 |
[Current surgical treatment for hepatocellular carcinoma : critical appraisal of current guidelines].
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
Topics: alpha-Fetoproteins; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization.
Topics: Biopsy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Acquired Hemophilia A After Hepatic Yttrium-90 Radioembolization: A Case Report.
Topics: Aged; Carcinoma, Hepatocellular; Factor VII; Hemophilia A; Humans; Liver Neoplasms; Male; Yttrium Radioisotopes | 2017 |
Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Prognosis; Survival Analysis; Yttrium Radioisotopes | 2018 |
Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Intraoperative Complications; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Preoperative Care; Risk; Thrombosis; Vascular Surgical Procedures; Yttrium Radioisotopes | 2018 |
The SIRveNIB and SARAH trials and the role of SIR-Spheres® Y-90 resin microspheres in the management of hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Humans; Liver Neoplasms; Microspheres; Multicenter Studies as Topic; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Grant, deny, or reassess the role of yttrium-90 in hepatocellular carcinoma?
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Hypertrophy; Liver; Liver Neoplasms; Male; Radiometry; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2018 |
Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.
Topics: Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiotherapy Dosage; Yttrium Radioisotopes | 2018 |
Prospective study to determine early hypertrophy of the contra-lateral liver lobe after unilobar, Yttrium-90, selective internal radiation therapy in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Hepatomegaly; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Yttrium Radioisotopes | 2018 |
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Portal Vein; Prognosis; Retrospective Studies; Yttrium Radioisotopes | 2018 |
Yttrium-90 Radioembolization of the Right Inferior Phrenic Artery in 20 Patients with Hepatocellular Carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Polyvinyl Alcohol; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Uncomplicated 90Y Selective Internal Radio Therapy in a Patient With Hepatocellular Carcinoma After Arterial and Portal Vein Embolizations.
Topics: Aged; Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Male; Microspheres; Portal Vein; Yttrium Radioisotopes | 2018 |
Negative phase 3 study of
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2018 |
Negative phase 3 study of
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2018 |
Negative phase 3 study of
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2018 |
Negative phase 3 study of
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2018 |
Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans; Liver; Middle Aged; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Prognosis; Yttrium Radioisotopes | 2018 |
Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Logistic Models; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2018 |
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Retrospective Studies; Sorafenib; Yttrium Radioisotopes | 2018 |
Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Iodine; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Reply to: "Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion".
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Yttrium Radioisotopes | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Cholangitis; Female; Glass; Humans; Infections; Liver; Liver Abscess; Liver Neoplasms; Male; Microspheres; Middle Aged; Retreatment; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Hepatectomy; Humans; Immunotherapy; Liver Neoplasms; Male; Nivolumab; Programmed Cell Death 1 Receptor; Radiofrequency Therapy; Yttrium Radioisotopes | 2018 |
Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Analysis; Thrombosis; Yttrium Radioisotopes | 2018 |
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Theranostic Nanomedicine; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Survival Analysis; Yttrium Radioisotopes | 2019 |
Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Regeneration; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Safety of Radioembolization in the Setting of Angiographically Apparent Arterioportal Shunting.
Topics: Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children.
Topics: Adolescent; Carcinoma, Hepatocellular; Child; Child, Preschool; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Survival Rate; Yttrium Radioisotopes | 2019 |
Hepatocellular Carcinoma in Abernethy Malformation: A Rare Occurrence of Congenital Complete Portosystemic Shunt.
Topics: Aged; Angiography, Digital Subtraction; Biopsy; Carcinoma, Hepatocellular; Computed Tomography Angiography; Embolization, Therapeutic; Female; Humans; Liver Circulation; Liver Neoplasms; Phlebography; Portal Vein; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Treatment Outcome; Vascular Malformations; Yttrium Radioisotopes | 2018 |
Evaluation of Early Response to Treatment of Hepatocellular Carcinoma with Yttrium-90 Radioembolization Using Quantitative Computed Tomography Analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Progression-Free Survival; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2019 |
Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2019 |
Radical Radial: Pearls and Pitfalls in Transradial Yttrium-90 Liver-Directed Therapy.
Topics: Carcinoma, Hepatocellular; Catheterization, Peripheral; Computed Tomography Angiography; Female; Humans; Liver Neoplasms; Male; Patient Selection; Radial Artery; Radiography, Interventional; Yttrium Radioisotopes | 2019 |
Technical Aspects and Practical Approach Toward Same-Day Y90 Radioembolization in the Management of Hepatocellular Carcinoma.
Topics: Aged; Ambulatory Care; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Male; Microspheres; Patient Selection; Radiopharmaceuticals; Radiotherapy Dosage; Technetium Tc 99m Aggregated Albumin; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.
Topics: Carcinoma, Hepatocellular; Consensus Development Conferences as Topic; Humans; Liver Neoplasms; Microspheres; Practice Guidelines as Topic; Radiometry; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Yttrium Radioisotopes | 2019 |
Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Portal Vein; Prognosis; Radionuclide Imaging; Survival Analysis; Venous Thrombosis; Yttrium Radioisotopes | 2019 |
The forgotten place of radioembolization for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Portal Vein; Venous Thrombosis; Yttrium Radioisotopes | 2017 |
Use of X-Ray Fluorescence Microscopy for Studies on Research Models of Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microscopy, Fluorescence; Rabbits; X-Rays; Yttrium Radioisotopes | 2021 |
Incidental Finding of Pulmonary Embolism at Workup Before SIRT.
Topics: Carcinoma, Hepatocellular; Humans; Incidental Findings; Liver Neoplasms; Pulmonary Embolism; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2022 |
Computational Modeling of Radioembolization: How to Calculate Infinity.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Computer Simulation; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Yttrium 90 Radioembolization for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2021 |
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2022 |
Balloon-assisted radioembolization via the proper hepatic artery to treat a left liver hepatocellular carcinoma and portal vein tumor thrombus with an inaccessible left hepatic artery: A case report.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Portal Vein; Retrospective Studies; Thrombosis; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Yttrium Radioisotopes | 2022 |
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2022 |
Role of nanoparticles in transarterial radioembolization with glass microspheres.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Nanoparticles; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2022 |
Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors.
Topics: Carcinoma, Hepatocellular; Cohort Studies; Humans; Liver Neoplasms; Liver Transplantation; Necrosis; Pneumonectomy; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Topics: Animals; Carcinoma, Hepatocellular; Fibroins; Iodine Radioisotopes; Liver Neoplasms; Microspheres; Rats; Tissue Distribution; Yttrium Radioisotopes | 2022 |
Spatial density and tumor dosimetry are important in radiation segmentectomy with
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Pneumonectomy; Radiometry; Yttrium Radioisotopes | 2022 |
Association of dysmorphic intratumoral vessel with high lung shunt fraction in patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2022 |
Radiation Segmentectomy for the Treatment of Primary Hepatic Malignancies of the Caudate Lobe: A Case Series.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Pneumonectomy; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study.
Topics: Aged; Ascites; Australia; Carcinoma, Hepatocellular; Cohort Studies; End Stage Liver Disease; Female; Humans; Liver Neoplasms; Male; Retrospective Studies; Severity of Illness Index; Sirtuins; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Reduction of Hepatopulmonary and Intrahepatic Shunts after Treatment with Sorafenib in Hepatocellular Carcinoma Patients.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Sorafenib; Treatment Outcome; Yttrium Radioisotopes | 2022 |
99m Tc-Macroaggregated Albumin Liver Lung Shunt Study With Uptake Indicative of Patent Falciform Artery.
Topics: Albumins; Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2023 |
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England.
Topics: Brachytherapy; Carbon Dioxide; Carcinoma, Hepatocellular; England; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2023 |
Prior ablation and progression of disease correlate with higher tumor-to-normal liver
Topics: Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2023 |
The evaluation of DLCO changes in patients with relatively higher lung shunt fractions receiving TARE.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung; Lung Injury; Microspheres; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Using Deep Learning to Predict Treatment Response in Patients with Hepatocellular Carcinoma Treated with Y90 Radiation Segmentectomy.
Topics: Carcinoma, Hepatocellular; Deep Learning; Humans; Liver Neoplasms; Pneumonectomy; Retrospective Studies; Yttrium Radioisotopes | 2023 |
Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Humans; Liver Neoplasms; Male; Propensity Score; Retrospective Studies; Survival Analysis; Yttrium Radioisotopes | 2023 |
Transarterial Radioembolization Ought Not to Borrow Future Liver Function from Patients with Hepatocellular Carcinoma. But Does It?
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Vascular Surgical Procedures; Yttrium Radioisotopes | 2023 |
Radioembolization for Intermediate-Stage Hepatocellular Carcinoma Maintains Liver Function and Permits Systemic Therapy at Progression.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2023 |
Short-term changes of angiogenesis factors after transarterial radioembolization in hepatocellular carcinoma patients.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Yttrium Radioisotopes | 2023 |
Radioembolization Planning With Dual-Isotope Acquisition of 166 Ho-Labeled Microparticles and 99m Tc-Mebrofenin.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Isotopes; Liver Neoplasms; Male; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2023 |
Safety of Radioembolization via the Cystic Artery in Patients with Hepatocellular Carcinoma and Parasitized Arterial Supply.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Ablative Radioembolization of a Synchronous Renal Cell Carcinoma and Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Chemoembolization, Therapeutic; Humans; Kidney Neoplasms; Liver Neoplasms; Yttrium Radioisotopes | 2023 |
Dosimetric assessment of Gadolinium-159 for hepatic radioembolization: Tomographic images and Monte Carlo simulation.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Monte Carlo Method; Yttrium Radioisotopes | 2023 |
Demonstration of therapy response to radioembolization with
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Positron-Emission Tomography; Yttrium Radioisotopes | 2023 |
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2023 |
Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Immunotherapy; Liver Neoplasms; Male; Middle Aged; Nivolumab; Patient Safety; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Yttrium Radioisotopes | 2020 |
Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung; Microspheres; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Acute Biliary Obstruction after Transarterial Radioembolization with Yttrium-90.
Topics: Carcinoma, Hepatocellular; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Quality of Life after Radioembolization for Hepatocellular Carcinoma Using a Digital Patient-Reported Outcome Tool.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Patient Reported Outcome Measures; Pilot Projects; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Models, Theoretical; Prognosis; Risk Assessment; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Miscalculated Lung Shunt Fraction for Planning of Hepatic Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung; Male; Medical Errors; Middle Aged; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2020 |
Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
Topics: Aged; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prognosis; Research Design; Retrospective Studies; Safety; Serum Albumin; Severity of Illness Index; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; CA-19-9 Antigen; Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Complex and Mixed; Phenotype; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Hypoxia; Liver Neoplasms; Lung; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Retrospective Studies; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2020 |
Radioembolization of hepatocarcinoma with
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2020 |
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Portal Vein; Retrospective Studies; Treatment Outcome; Venous Thrombosis; Young Adult; Yttrium Radioisotopes | 2020 |
Radioembolization-induced Tumor Calcifications as a Surrogate Marker of Tumor Response in Patients With Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcinosis; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2020 |
Androgen-receptor-positive hepatocellular carcinoma in a transgender teenager taking exogenous testosterone.
Topics: Adolescent; Androgens; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Radiopharmaceuticals; Receptors, Androgen; Sex Reassignment Procedures; Testosterone; Transgender Persons; Transsexualism; Yttrium Radioisotopes | 2020 |
Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Necrosis; Radiation Dosage; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Heart Atria; Heart Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging, Cine; Male; Neoplasm Invasiveness; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Yttrium-90 Radioembolization in the Office-Based Lab.
Topics: Aged; Ambulatory Care Facilities; Angiography; Appointments and Schedules; Carcinoma, Hepatocellular; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Program Evaluation; Radiology Department, Hospital; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Workflow; Yttrium Radioisotopes | 2020 |
Assessment of Hepatocellular Carcinoma Response to
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Prospective Studies; Yttrium Radioisotopes | 2020 |
SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study).
Topics: Aged; Aged, 80 and over; Australia; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Disease-Free Survival; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Europe; Female; Humans; Incidence; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Radiography; Registries; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; France; Humans; Incidence; Liver Neoplasms; Male; Neoplasms, Second Primary; Quality of Life; Yttrium Radioisotopes | 2021 |
Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nivolumab; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study.
Topics: Ablation Techniques; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver Neoplasms; Male; Microwaves; Middle Aged; Propensity Score; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Databases, Factual; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Radioembolization Versus Chemoembolization for Neuroendocrine Metastases.
Topics: Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Neuroendocrine Tumors; Yttrium Radioisotopes | 2021 |
Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; End Stage Liver Disease; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation Study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Middle Aged; Necrosis; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2021 |
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization.
Topics: Carcinoma, Hepatocellular; End Stage Liver Disease; Female; Humans; Liver Neoplasms; Male; Middle Aged; Severity of Illness Index; Yttrium Radioisotopes | 2021 |
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.
Topics: Aged; Albumins; Carcinoma, Hepatocellular; Female; Glass; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2021 |
Does significantly elevated lung shunt fraction (LSF >20%) promote extrahepatic progression in patients with hepatocellular carcinoma treated with radioembolization?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2021 |
Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?
Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2021 |
Bilioenteric Fistula following Segmental Transarterial Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Fistula; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Transarterial Radioembolization for Hepatocellular Carcinoma with Major Vascular Invasion: A Nationwide Propensity Score-Matched Analysis with Target Trial Emulation.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Propensity Score; Prospective Studies; Yttrium Radioisotopes | 2021 |
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.
Topics: Aged; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Topics: Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Embolization, Therapeutic; Humans; Kidney Neoplasms; Liver; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Doxorubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Propensity Score; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2017 |
RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
Topics: Age Factors; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatomegaly; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Platelet Count; Radiopharmaceuticals; Retrospective Studies; Severity of Illness Index; Spleen; Tomography, X-Ray Computed; Tumor Burden; Yttrium Radioisotopes | 2017 |
Incident of Stroke after Transradial Arterial Access for Subdiaphragmatic Intervention.
Topics: Aged, 80 and over; Anticoagulants; Carcinoma, Hepatocellular; Catheterization, Peripheral; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Radial Artery; Stroke; Tomography, X-Ray Computed; Ultrasonography, Interventional; Yttrium Radioisotopes | 2017 |
Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Disease-Free Survival; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Propensity Score; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2017 |
Radioembolization for hepatocellular carcinoma: The time has come.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Fatal Outcome; Hepatectomy; Humans; Liver Neoplasms; Male; Neoadjuvant Therapy; Radiography, Interventional; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
Topics: Adult; Aged; Analysis of Variance; Brachytherapy; Cancer Care Facilities; Carcinoma, Hepatocellular; Cohort Studies; Decision Making; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Radiation Injuries; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome; United States; Yttrium Radioisotopes | 2018 |
"Snuffbox" Distal Radial Access.
Topics: Aged; Arteriovenous Shunt, Surgical; Carcinoma, Hepatocellular; Fluoroscopy; Hand; Hemostasis, Surgical; Humans; Liver Neoplasms; Male; Patient Positioning; Radial Artery; Technetium Tc 99m Aggregated Albumin; Ultrasonography, Interventional; Yttrium Radioisotopes | 2018 |
Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.
Topics: Adult; Aged; Belgium; Carcinoma, Hepatocellular; Feasibility Studies; Female; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Prospective Studies; Radiofrequency Ablation; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Survival comparison of hepatocellular carcinoma patients treated with radioembolization versus nonoperative/interventional treatment.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Propensity Score; Radioisotopes; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Cancer Survivors; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Yttrium Radioisotopes | 2018 |
Clinical utility of one month imaging following selective internal radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Clinical Decision-Making; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2019 |
Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm.
Topics: Aged; Biliary Tract; Carcinoma, Hepatocellular; Computed Tomography Angiography; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Phlebography; Progression-Free Survival; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Time Factors; Tumor Burden; Yttrium Radioisotopes | 2019 |
Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Prospective Studies; Quality of Life; Response Evaluation Criteria in Solid Tumors; Surveys and Questionnaires; Yttrium Radioisotopes | 2019 |
Sorafenib Reduced Significantly Heptopulmonary Shunt in a Large Hepatocelullar Carcinoma.
Topics: Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Humans; Liver Neoplasms; Male; Radiopharmaceuticals; Sorafenib; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2019 |
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2018 |
90Y-TheraSpheres: The New Look of Yttrium-90.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Microscopy, Polarization; Microspheres; Middle Aged; Particle Size; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Clinical Decision-Making; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Patient Selection; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Ablative Transarterial Radioembolization of a Parasitized Adrenal Artery for the Treatment of Hepatocellular Carcinoma.
Topics: Adrenal Glands; Angiography; Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Postoperative Complications; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Prediction of hepatocellular carcinoma response to
Topics: Adult; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; ROC Curve; Yttrium Radioisotopes | 2019 |
Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Combined Modality Therapy; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Progression-Free Survival; Radiofrequency Ablation; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Yttrium Radioisotopes | 2019 |
Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Drug Carriers; Humans; Liver Neoplasms; Patient Selection; Practice Guidelines as Topic; Survival Rate; Yttrium Radioisotopes | 2013 |
Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Radiotherapy, Adjuvant; Sorafenib; Yttrium Radioisotopes | 2013 |
Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Clinical Trials as Topic; Disease Progression; Eligibility Determination; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prospective Studies; Radiopharmaceuticals; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?
Topics: Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Hypertrophy; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Neoadjuvant Therapy; Organ Size; Preoperative Care; Radiotherapy, Adjuvant; Retrospective Studies; Tumor Burden; Yttrium Radioisotopes | 2013 |
Standards of practice in transarterial radioembolization.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contraindications; Humans; Liver Neoplasms; Microspheres; Radiography, Interventional; Radiotherapy Dosage; Yttrium Radioisotopes | 2013 |
Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Hypertension, Portal; Liver Neoplasms; Portasystemic Shunt, Transjugular Intrahepatic; Yttrium Radioisotopes | 2013 |
Basophilic round bodies in gastric biopsies little known by pathologists: iatrogenic yttrium 90 microspheres deriving from selective internal radiation therapy.
Topics: Aged; Biopsy; Brachytherapy; Carcinoma, Hepatocellular; Gastric Mucosa; Humans; Liver Neoplasms; Male; Microspheres; Radiotherapy; Stomach Diseases; Yttrium Radioisotopes | 2013 |
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.
Topics: Carcinoma, Hepatocellular; Female; Glass; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Precision Medicine; Radiometry; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Safety; Survival Analysis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Downstaging to liver resection by radioembolization: a difficult to reach strategy? Author reply.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Yttrium Radioisotopes | 2013 |
Downstaging to liver resection by radioembolization: a difficult to reach strategy?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Yttrium Radioisotopes | 2013 |
Posttreatment PET-CT-confirmed intrahepatic radioembolization performed without coil embolization, by using the antireflux Surefire Infusion System.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Palliative Care; Positron-Emission Tomography; Radiography, Interventional; Risk Assessment; Sampling Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Portal Vein; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2013 |
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Organ Size; Survival Rate; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Venous Thrombosis; Yttrium Radioisotopes | 2013 |
Treatment of hepatocellular carcinoma with radioembolization: gathering assumptions for trial design.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials as Topic; Female; Humans; Liver Neoplasms; Male; Patient Selection; Radiopharmaceuticals; Yttrium Radioisotopes | 2013 |
Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Programmed cell death in a patient with hepatocellular carcinoma treated with yttrium-90 and doxorubicin-loaded beads.
Topics: Apoptosis Regulatory Proteins; Autophagy; Capsules; Carcinoma, Hepatocellular; Chemoradiotherapy; Delayed-Action Preparations; Doxorubicin; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Treatment Outcome; Waiting Lists; Yttrium Radioisotopes | 2013 |
Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Organ Size; Yttrium Radioisotopes | 2014 |
Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.
Topics: Adult; Aged; Aged, 80 and over; Angiogenic Proteins; Biomarkers, Tumor; Carcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Cytokines; Embolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neovascularization, Pathologic; Pilot Projects; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Resins, Synthetic; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Multimodal Imaging; Resins, Synthetic; Thrombosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
A surreptitious trip to the lungs.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung; Male; Radiation Pneumonitis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
Intraprocedural yttrium-90 positron emission tomography/CT for treatment optimization of yttrium-90 radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Glass; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Portal Vein; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2014 |
The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).
Topics: Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Microspheres; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Prospective Studies; Protein Kinase Inhibitors; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Factors; Sorafenib; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Gamma Cameras; Hepatopulmonary Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Technetium Tc 99m Aggregated Albumin; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Yttrium Radioisotopes | 2014 |
Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.
Topics: Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Decision Support Techniques; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Linear Models; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Databases, Factual; Disease Progression; Feasibility Studies; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Radiotherapy; Risk Factors; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Topics: Aged; Carcinoma, Hepatocellular; Cohort Studies; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.
Topics: Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2014 |
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Case-Control Studies; Cause of Death; Embolization, Therapeutic; Female; Humans; Italy; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Propensity Score; Retrospective Studies; Sorafenib; Yttrium Radioisotopes | 2015 |
Reply: To PMID 24691943.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Female; Humans; Liver Neoplasms; Male; Radiotherapy; Yttrium Radioisotopes | 2015 |
Is segmental transarterial yttrium 90 radiation a curative option for solitary hepatocellular carcinoma ≤5 cm?
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Female; Humans; Liver Neoplasms; Male; Radiotherapy; Yttrium Radioisotopes | 2015 |
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Yttrium Radioisotopes | 2014 |
Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertrophy; Liver; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Risk Factors; Yttrium Radioisotopes | 2014 |
Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Topics: Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2014 |
The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2014 |
Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Hepatectomy; Hepatolenticular Degeneration; Humans; Liver Neoplasms; Liver Transplantation; Microspheres; Middle Aged; Prognosis; Yttrium Radioisotopes | 2014 |
Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Glass; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2014 |
Usefulness of radioembolization in identifying patients with favorable tumor biology before living donor liver transplantation.
Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2014 |
PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Computer Simulation; Embolization, Therapeutic; Esophageal Neoplasms; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Signal-To-Noise Ratio; Tissue Distribution; Yttrium Radioisotopes | 2014 |
Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Drug Stability; Ethiodized Oil; Feasibility Studies; Humans; Isotope Labeling; Liver Neoplasms; Materials Testing; Phenanthrolines; Radiopharmaceuticals; Thiocarbamates; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gastrectomy; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Radiopharmaceuticals; Stomach; Stomach Ulcer; Yttrium Radioisotopes | 2014 |
Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Microspheres; Middle Aged; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Apparent diffusion coefficient quantification as an early imaging biomarker of response for unresectable infiltrative hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?
Topics: Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Evaluation of Liver Stiffness After Radioembolization by Real-Time ShearWave™ Elastography: Preliminary Study.
Topics: Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Female; Follow-Up Studies; Hepatitis B; Hepatitis C; Humans; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Yttrium Radioisotopes | 2015 |
Hepatopulmonary shunting in patients with primary and secondary liver tumors scheduled for radioembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urologic Neoplasms; Yttrium Radioisotopes | 2015 |
90Yttrium PET/MR-based dosimetry after liver radioembolization (SIRT).
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tissue Distribution; Yttrium Radioisotopes | 2015 |
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Europe; False Positive Reactions; Female; Glass; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Radiometry; Retrospective Studies; Sorafenib; Thrombosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Sorafenib- or 90Y-loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust?
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Yttrium Radioisotopes | 2015 |
Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Portal Vein; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Middle Aged; Neoplasm Staging; Preoperative Care; Retrospective Studies; Yttrium Radioisotopes | 2015 |
Reply to: "Sorafenib or (90) Y loaded resin microsphere radioembolization for locally-advanced hepatocellular carcinoma, what should we trust?".
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Yttrium Radioisotopes | 2015 |
The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.
Topics: Aged; Area Under Curve; Carcinoma, Hepatocellular; Chi-Square Distribution; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutrophils; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Hepatocellular; Cross-Sectional Studies; Embolization, Therapeutic; Female; Holmium; Humans; Liver; Liver Neoplasms; Lung; Male; Microspheres; Middle Aged; Phantoms, Imaging; Radioisotopes; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2015 |
Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Topics: Carcinoma, Hepatocellular; Child; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Glass; Humans; Liver Neoplasms; Microspheres; Precision Medicine; Radiobiology; Radiometry; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2015 |
Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portal Vein; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate; Venous Thrombosis; Yttrium Radioisotopes | 2015 |
Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Data Interpretation, Statistical; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2016 |
A computational tool for patient specific dosimetry and radiobiological modeling of selective internal radiation therapy with (90)Y microspheres.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Male; Microspheres; Middle Aged; Patient-Specific Modeling; Positron-Emission Tomography; Radiobiology; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2015 |
Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Causality; Comorbidity; Female; Glass; Hepatitis B; Humans; Liver Neoplasms; Male; Microspheres; New York; Prevalence; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
Topics: Aged; Angiography, Digital Subtraction; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholestasis; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2015 |
Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Medicare; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Propensity Score; SEER Program; Survival Rate; Tumor Burden; United States; Yttrium Radioisotopes | 2015 |
Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Diagnostic Imaging; Embolization, Therapeutic; Humans; Liver Neoplasms; Materials Testing; Microspheres; Neutrons; Particle Size; Postoperative Period; Radioisotopes; Radionuclide Imaging; Resins, Synthetic; Samarium; Yttrium Radioisotopes | 2015 |
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Radiopharmaceuticals; Sorafenib; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Venous Thrombosis; Young Adult; Yttrium Radioisotopes | 2015 |
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Cholangiocarcinoma; Deoxycytidine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Synergism; Gemcitabine; Humans; Niacinamide; Organoplatinum Compounds; Paclitaxel; Phenylurea Compounds; Pyridines; Radiation Tolerance; Radiopharmaceuticals; Sorafenib; Yttrium Radioisotopes | 2015 |
A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Logistic Models; Male; Microspheres; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Propensity Score; Radiopharmaceuticals; Retrospective Studies; Sorafenib; Spain; Survival Analysis; Yttrium Radioisotopes | 2016 |
Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Portal Vein; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Sorafenib; Thrombosis; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Bilirubin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Chicago; Databases, Factual; Discriminant Analysis; Doxorubicin; Ethiodized Oil; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors; Serum Albumin; Serum Albumin, Human; Time Factors; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2016 |
Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
Topics: Aged; alpha-Fetoproteins; Aspartate Aminotransferases; Bilirubin; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Glass; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Invasiveness; New York City; Portal Vein; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Propensity Score; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Sorafenib; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2016 |
Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Salvage Therapy; Time Factors; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2016 |
[Selective internal radioembolization in nonresectable hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Chemoradiotherapy; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Middle Aged; Neoplasm Staging; Palliative Care; Prospective Studies; Survival Analysis; Yttrium Radioisotopes | 2016 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Yttrium Radioisotopes | 2017 |
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; France; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Logistic Models; Male; Microspheres; Middle Aged; Multivariate Analysis; Portal Vein; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Venous Thrombosis; Yttrium Radioisotopes | 2017 |
Arterial Changes Due to Chemoembolization of Hepatocellular Carcinoma Impacting Subsequent Radioembolization.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Collateral Circulation; Computed Tomography Angiography; Cone-Beam Computed Tomography; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Neoplasm, Residual; Radiopharmaceuticals; Regional Blood Flow; Retreatment; Treatment Outcome; Yttrium Radioisotopes | 2016 |
The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung Injury; Predictive Value of Tests; Radiation Dosage; Radiation Exposure; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2016 |
Preliminary evaluation of indigenous
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Embolization, Therapeutic; Humans; India; Liver; Liver Neoplasms; Microspheres; Neoplasms, Experimental; Rats; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Transradial Approach for Hepatic Radioembolization: Initial Results and Technique.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radial Artery; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Calculation of tumour and normal tissue biological effective dose in
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Microspheres; Radiation Dosage; Radiometry; Radiotherapy Dosage; Relative Biological Effectiveness; Yttrium Radioisotopes | 2016 |
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Eye Neoplasms; Hepatectomy; Humans; Length of Stay; Liver Neoplasms; Melanoma; Middle Aged; Neuroendocrine Tumors; Patient Readmission; Postoperative Complications; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2017 |
Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Tissue and Organ Procurement; Waiting Lists; Young Adult; Yttrium Radioisotopes | 2017 |
Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Radioembolization for hepatocellular carcinoma: gaining insight on a personalized approach.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Florida; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Lung Shunting: An Indicator of Survival, But Not Necessarily a Tool for Selecting Patients for Radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Contrast Media; Elasticity Imaging Techniques; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Retrospective Studies; Subtraction Technique; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Prognostic Nutritional Index Is Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nutrition Assessment; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2017 |
90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Fibrosis; Humans; Immunohistochemistry; Liver Neoplasms; Male; Microspheres; Middle Aged; Necrosis; Retrospective Studies; Yttrium Radioisotopes | 2009 |
Duodenal ulcer due to yttrium microspheres used for selective internal radiation therapy of hepatocellular cancer.
Topics: Aged; Carcinoma, Hepatocellular; Duodenal Ulcer; Humans; Liver Neoplasms; Male; Microspheres; Yttrium Radioisotopes | 2009 |
Regional radioactive treatments for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Liver Neoplasms; Microspheres; Radiotherapy; Yttrium Radioisotopes | 2008 |
Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report.
Topics: Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cohort Studies; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Necrosis; Time Factors; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2009 |
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Models, Chemical; Radiation Injuries; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Organ Size; Yttrium Radioisotopes | 2009 |
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2009 |
Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Albumins; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Brachytherapy; Carcinoma, Hepatocellular; Cholinesterases; Embolization, Therapeutic; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2009 |
A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Staging; Patient Selection; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Is downstaging prior to liver transplantation important in hepatocellular carcinoma?
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Patient Selection; Yttrium Radioisotopes | 2009 |
Y-90 microsphere therapy: prevention of adverse events.
Topics: Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Humans; Liver Neoplasms; Microspheres; Radiation Injuries; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Gastric radiation enteritis after intra-arterial yttrium-90 microsphere therapy for early stage hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Enteral Nutrition; Female; Gastric Bypass; Gastritis; Gastroscopy; Hepatitis C; Humans; Injections, Intra-Arterial; Jejunostomy; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Microspheres; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2009 |
First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Injections; Liver Neoplasms; Male; Microspheres; Middle Aged; Occupational Exposure; Physicians; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2010 |
Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
Topics: Aged; Carcinoma, Hepatocellular; Drug Stability; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Pilot Projects; Prospective Studies; Radiation Dosage; Radiography, Interventional; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2009 |
[Liver chemoembolization: an update].
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Contraindications; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Neuroendocrine Tumors; Yttrium Radioisotopes | 2009 |
Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Comorbidity; Female; Hepatic Veins; Humans; Incidence; Liver Neoplasms; Male; Microspheres; Middle Aged; Minnesota; Pulmonary Embolism; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2009 |
Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Databases as Topic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pilot Projects; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Yttrium-90 radioembolization in the management of liver tumors: expanding the global experience.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Internationality; Liver Neoplasms; Yttrium Radioisotopes | 2010 |
[Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Comorbidity; Early Diagnosis; Embolization, Therapeutic; Female; Hemochromatosis; Hepatectomy; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Mass Screening; Niacinamide; Obesity; Phenylurea Compounds; Prospective Studies; Pyridines; Registries; Retrospective Studies; Sorafenib; Spain; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2010 |
Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Analysis of Variance; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Tumor Burden; Yttrium Radioisotopes | 2010 |
Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Female; Hepatic Artery; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Radionuclide Imaging; Survival Analysis; Yttrium Radioisotopes | 2010 |
Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Outcome Assessment, Health Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Brachytherapy; Carcinoma, Hepatocellular; Collateral Circulation; Embolization, Therapeutic; Female; Gastrointestinal Tract; Humans; Image Processing, Computer-Assisted; Liver Circulation; Liver Neoplasms; Male; Microspheres; Middle Aged; Regional Blood Flow; Sensitivity and Specificity; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2010 |
Cholecystoduodenal fistula after yttrium-90 radioembolization.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Intestinal Fistula; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Yttrium Radioisotopes | 2010 |
Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Confidence Intervals; Embolization, Therapeutic; Female; Guidelines as Topic; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Necrosis; Radiation Injuries; Radiography; Radiotherapy Dosage; Survival Analysis; Tumor Burden; Yttrium Radioisotopes | 2011 |
Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatic Artery; Hepatitis B; Humans; Liver Neoplasms; Liver Transplantation; Microspheres; Middle Aged; Neoplasm Staging; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Treatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy.
Topics: Aged; Carcinoma, Hepatocellular; Cohort Studies; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Necrosis; Observer Variation; Organ Size; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2011 |
Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.
Topics: Adolescent; Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; North Carolina; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Venous Thrombosis; Young Adult; Yttrium Radioisotopes | 2010 |
A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Radiobiology; Radiometry; Radiotherapy; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Model-based radiation dose correction for yttrium-90 microsphere treatment of liver tumors with central necrosis.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Models, Biological; Monte Carlo Method; Necrosis; Radionuclide Imaging; Radiotherapy Dosage; Technology, Radiologic; Tumor Burden; Yttrium Radioisotopes | 2011 |
Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
Topics: Algorithms; Beta Particles; Brachytherapy; Carcinoma, Hepatocellular; Consensus; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Microvessels; Patient Selection; Practice Guidelines as Topic; Sulfhydryl Compounds; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2012 |
Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Yttrium Radioisotopes | 2010 |
Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma.
Topics: Aged; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Microspheres; Thrombocytopenia; Yttrium Radioisotopes | 2010 |
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
Topics: Aged; Algorithms; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Safety; Survivors; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Trials, Phase II as Topic; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Standard of Care; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.
Topics: Adult; Aged; Angiography; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Feasibility Studies; Female; Gallbladder; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Radiation Injuries; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Transarterial radioembolization with Yttrium-90 for regional management of hepatocellular cancer: the early results of a nontransplant center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2010 |
Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
⁹⁰Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT).
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Systems Integration; Yttrium Radioisotopes | 2011 |
Peripheral blood lymphocyte depletion after hepatic arterial 90Yttrium microsphere therapy for hepatocellular carcinoma.
Topics: Blood Platelets; Carcinoma, Hepatocellular; Female; Granulocytes; Humans; Killer Cells, Natural; Leukocytes; Liver Neoplasms; Lymphocyte Depletion; Lymphocyte Subsets; Lymphopenia; Male; Microspheres; Middle Aged; Yttrium Radioisotopes | 2012 |
Thrombocytopenia following 90Yttrium glass microsphere liver radioembolization.
Topics: Aged; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Platelet Count; Thrombocytopenia; Yttrium Radioisotopes | 2011 |
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Yttrium Radioisotopes | 2011 |
Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin in hepatic perfusion imaging studies prior to yttrium-90 microsphere therapy.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Perfusion; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2011 |
Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital.
Topics: Aged; Aged, 80 and over; Belgium; Carcinoma, Hepatocellular; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Longitudinal Studies; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.
Topics: Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Turkey; Yttrium Radioisotopes | 2011 |
Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled mic
Topics: Aged; Albumins; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Organ Size; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Collateral Circulation; Colorectal Neoplasms; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Neovascularization, Pathologic; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Invited commentary.
Topics: Angiography; Angiography, Digital Subtraction; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Research Report; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; United States; Yttrium Radioisotopes | 2011 |
Radioembolisation of hepatocellular carcinoma patients using ⁹⁰Y-labelled microspheres: towards a diffusion of the technique?
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Yttrium Radioisotopes | 2011 |
Survival after accidental extrahepatic distribution of Y90 microspheres to the mesentery during a radioembolization procedure.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluoroscopy; Humans; Liver Neoplasms; Mesentery; Microspheres; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2012 |
MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Necrosis; Radiographic Image Enhancement; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Yttrium-90 time-of-flight PET/CT is superior to Bremsstrahlung SPECT/CT for postradioembolization imaging of microsphere biodistribution.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Topics: Carcinoma, Hepatocellular; Feasibility Studies; Humans; Liver; Liver Neoplasms; Microspheres; Organs at Risk; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Software; Time Factors; Yttrium Radioisotopes | 2011 |
Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Yttrium 90 therapy for hepatocellular carcinoma: Is it any better than conventional external beam radiotherapy?
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Yttrium Radioisotopes | 2012 |
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Glass; Humans; Liver Neoplasms; Male; Microspheres; Multimodal Imaging; Positron-Emission Tomography; Radiometry; Retrospective Studies; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
Topics: Aged; Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Middle Aged; Models, Biological; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Precision Medicine; Radiometry; Retrospective Studies; Safety; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Evaluation of S-values and dose distributions for (90)Y, (131)I, (166)Ho, and (188)Re in seven lobes of the rat liver.
Topics: Animals; Carcinoma, Hepatocellular; Electrons; Holmium; Iodine Radioisotopes; Liver; Liver Neoplasms; Monte Carlo Method; Photons; Radiation Dosage; Rats; Rats, Sprague-Dawley; Rhenium; Yttrium Radioisotopes | 2012 |
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Microspheres; Middle Aged; Neoplasm Staging; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Chemoembolic hepatopulmonary shunt reduction to allow safe yttrium-90 radioembolization lobectomy of hepatocellular carcinoma.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Hepatopulmonary Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Portal Vein; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2012 |
A new catheter for tumor targeting with radioactive microspheres in representative hepatic artery systems. Part I: impact of catheter presence on local blood flow and microsphere delivery.
Topics: Carcinoma, Hepatocellular; Catheters; Drug Delivery Systems; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Regional Blood Flow; Yttrium Radioisotopes | 2012 |
Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Movement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Respiration; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Embolization, Therapeutic; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.
Topics: Adult; Aged; Angiography, Digital Subtraction; Brachytherapy; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Assessment; Survival Rate; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Patient Selection; Portal Vein; Venous Thrombosis; Yttrium Radioisotopes | 2013 |
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Case-Control Studies; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Registries; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Yttrium 90 radioembolization: the horizon is changing for patients with intermediate and advanced hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Severity of Illness Index; Yttrium Radioisotopes | 2013 |
Radioembolisation for treatment of pediatric hepatocellular carcinoma.
Topics: Adolescent; Brachytherapy; Carcinoma, Hepatocellular; Child; Diagnostic Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Prognostic factors and prevention of radioembolization-induced liver disease.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Incidence; Jaundice; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiation Injuries; Severity of Illness Index; Yttrium Radioisotopes | 2013 |
Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.
Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Humans; Imaging, Three-Dimensional; Iodine Radioisotopes; Liver Neoplasms; Lutetium; Lymphoma, Non-Hodgkin; Microspheres; Models, Statistical; Monte Carlo Method; Neuroendocrine Tumors; Radioisotopes; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Yttrium Radioisotopes | 2013 |
How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2012 |
Safety of repeated yttrium-90 radioembolization.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Liver; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Middle Aged; Odds Ratio; Radiation Injuries; Retreatment; Retrospective Studies; Risk Factors; Yttrium Radioisotopes | 2013 |
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Interventional nuclear medicine in hepatocellular carcinoma and other tumours.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Microspheres; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Outcome; Yttrium Radioisotopes | 2002 |
Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver.
Topics: Aged; Carcinoma, Hepatocellular; Embolism; Embolization, Therapeutic; Female; Gallbladder; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2003 |
Model of metastatic growth valuable for radionuclide therapy.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Division; Computer Simulation; Dose-Response Relationship, Radiation; Humans; Liver Neoplasms; Lutetium; Models, Biological; Neoplasm Staging; Prognosis; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Relative Biological Effectiveness; Rhodium; Treatment Outcome; Yttrium Radioisotopes | 2003 |
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.
Topics: Carcinoma, Hepatocellular; Cause of Death; Chemoembolization, Therapeutic; Glass; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Patient Care Planning; Patient Selection; Survival Analysis; Yttrium Radioisotopes | 2004 |
Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Portal Vein; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Yttrium Radioisotopes | 2004 |
Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.
Topics: Body Burden; Brachytherapy; Carcinoma, Hepatocellular; Coated Materials, Biocompatible; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Injections, Intra-Arterial; Liver; Liver Neoplasms; Microspheres; Organ Specificity; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Relative Biological Effectiveness; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2004 |
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Survival Analysis; Yttrium Radioisotopes | 2004 |
Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Catheterization; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2004 |
Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Hepatic Artery; Humans; Liver; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome; Yttrium Radioisotopes | 2005 |
The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Hepatic Artery; Hepatitis B; Hepatitis C; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Viral Load; Yttrium Radioisotopes | 2005 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Topics: Adult; Aged; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Radiography, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2005 |
Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.
Topics: Adult; Carcinoma, Hepatocellular; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Neoplasm Staging; Yttrium Radioisotopes | 2005 |
Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Middle Aged; Yttrium Radioisotopes | 2006 |
Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2006 |
Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Radiotherapy Dosage; Statistics, Nonparametric; Yttrium Radioisotopes | 2006 |
Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a case report.
Topics: Adult; Carcinoma, Hepatocellular; Hepatitis C; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome; Yttrium Radioisotopes | 2006 |
Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Microspheres; Neoplasm Staging; Radiometry; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2006 |
Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cholecystitis; Female; Fibrosis; Humans; Hypertension, Portal; Liver Neoplasms; Male; Microspheres; Middle Aged; Peptic Ulcer; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2007 |
Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Survival Rate; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2007 |
Radiographically identified necrosis after 90Y microsphere brachytherapy: a new standard for oncologic response assessment?
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Necrosis; Nuclear Proteins; Radiographic Image Interpretation, Computer-Assisted; Reference Standards; Reproducibility of Results; Risk Assessment; Risk Factors; RNA-Binding Proteins; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
Topics: Brachytherapy; Canada; Carcinoma, Hepatocellular; Device Approval; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Diseases; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; United States; Yttrium Radioisotopes | 2007 |
90Yttrium microspheres for nonresectable liver cancer: the University of Connecticut Health Center experience.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Connecticut; Female; Hospitals, University; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2007 |
18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.
Topics: Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Yttrium Radioisotopes | 2007 |
Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Catheter Ablation; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2008 |
The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2008 |
Biliary complications associated with selective internal radiation (SIR) therapy for unresectable liver malignancies.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Cholangitis; Cholestasis; Humans; Jaundice, Obstructive; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiation Injuries; Radiotherapy; Yttrium Radioisotopes | 2008 |
Treatment of primary and secondary liver tumours with selective internal radiation therapy.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Yttrium Radioisotopes | 2007 |
Late gastric ulceration and cytomegalovirus infection following selective internal radiation therapy (SIRT) of the liver.
Topics: Aged; Ascites; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cytomegalovirus Infections; Diabetes Mellitus; Hepatic Artery; Humans; Hypertension; Hypertension, Portal; Infusions, Intra-Arterial; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Neoplasm Recurrence, Local; Stomach Ulcer; Yttrium Radioisotopes | 2008 |
Biliary sequelae following radioembolization with Yttrium-90 microspheres.
Topics: Biliary Tract; Bilirubin; Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.
Topics: Adult; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiation Pneumonitis; Radiography; Yttrium Radioisotopes | 1995 |
[Methods for the superselective radioembolization of liver tumors with 90yttrium-resin particles].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cation Exchange Resins; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Organotechnetium Compounds; Particle Size; Radionuclide Imaging; Resins, Plant; Resins, Synthetic; Tomography, X-Ray Computed; Yttrium Radioisotopes | 1994 |
Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings.
Topics: Adult; Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Microspheres; Radiation Pneumonitis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 1994 |
Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Glass; Humans; Injections, Intralesional; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Ultrasonography, Interventional; Yttrium Radioisotopes | 1996 |
Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Female; Humans; Liver; Liver Neoplasms; Lung; Male; Microspheres; Middle Aged; Models, Theoretical; Radiation Dosage; Radionuclide Imaging; Radiotherapy Dosage; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 1996 |
Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.
Topics: Adult; Brachytherapy; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Female; Humans; Liver; Liver Neoplasms; Lung; Male; Microspheres; Middle Aged; Models, Theoretical; Radiation Dosage; Radiation Pneumonitis; Radionuclide Imaging; Radiotherapy Dosage; Risk Factors; Survival Rate; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 1997 |
Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Humans; Liver; Liver Neoplasms; Microspheres; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 1997 |
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cause of Death; Dose Fractionation, Radiation; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Survival Analysis; Yttrium Radioisotopes | 1998 |
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Proportional Hazards Models; Radiotherapy Dosage; Survival Analysis; Survival Rate; Yttrium Radioisotopes | 2000 |
Treatment of hepatocellular carcinoma: a pivotal role for nuclear medicine?
Topics: Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Mice; Radiopharmaceuticals; Yttrium Radioisotopes | 2001 |
Intra-tumoural injection of 90Y microspheres into an animal model of hepatoma.
Topics: Absorption; Animals; Carcinoma, Hepatocellular; Injections; Liver Neoplasms; Male; Microspheres; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution; Yttrium Radioisotopes | 2001 |
Intrahepatic (90)Y-microspheres for hepatocellular carcinoma.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2001 |
Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Glass; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Yttrium Radioisotopes | 1999 |
Combating hepatocellular carcinoma with an integrated approach.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Humans; Iodine Radioisotopes; Liver Neoplasms; Microspheres; Radiotherapy, Adjuvant; Yttrium Radioisotopes | 1999 |
Selective internal radiation therapy by yttrium-90 microspheres for hepatocellular carcinoma after renal transplantation.
Topics: Adult; Brachytherapy; Carcinoma, Hepatocellular; Female; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2001 |
Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2001 |
[90Y glass microspheres intraradiopraxis of advanced hepatic carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Treatment Outcome; Yttrium Radioisotopes | 1998 |
Internal radiation therapy of liver cancer (90-Yttrium resin spheres intra-arterially) to supplement external radiation therapy, local and systemic chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver Neoplasms; Lomustine; Male; Middle Aged; Vincristine; Yttrium Radioisotopes | 1977 |
Intrahepatic arterial 90-yttrium resin spheres to treat liver cancer.
Topics: Adult; Carcinoma, Hepatocellular; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Neoplasm Metastasis; Radiotherapy Dosage; Resins, Plant; Yttrium Radioisotopes | 1978 |
Dosimetry and treatment planning in radioimmunotherapy.
Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Ferritins; Humans; Immunotherapy; Iodine Radioisotopes; Liver; Liver Neoplasms; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Yttrium Radioisotopes | 1990 |
Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Glass; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Pilot Projects; Yttrium Radioisotopes | 1989 |
Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Cell Line; Ferritins; Humans; Immunotherapy; Iodine Radioisotopes; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Yttrium Radioisotopes | 1989 |
Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma.
Topics: Antibodies; Carcinoma, Hepatocellular; Ferritins; Humans; Liver Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes | 1988 |
90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
Topics: Antibodies; Carcinoma, Hepatocellular; Drug Evaluation; Ferritins; Humans; Immunotherapy; Iodine Radioisotopes; Liver Neoplasms; Metabolic Clearance Rate; Radiotherapy; Radiotherapy Dosage; Yttrium Radioisotopes | 1986 |